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EFFECTS OF ISCHEMIC METABOLITES AND CHRONIC EXERCISE ON CARDIAC 
MYOCYTE FUNCTION 
 
ABSTRACT 
 The pumping action of the heart provides water, O2 and nutrients to all tissues and 
helps remove metabolic breakdown products and other wastes.  During times of low blood 
flow (ischemia), concentrations of wastes increase in tissues, which can lead to decreased 
striated muscle contractile function.  Acute contractile dysfunction during ischemia is likely 
mediated by build-up of inorganic phosphate (Pi) and protons (H+) (i.e., decreased pH).  The 
focus of this dissertation is examination of the myofibrillar mechanisms by which ischemic 
metabolites alter the work capacity of cardiac myocytes, which ultimately comprise 
ventricular pump function.  In addition, contractile properties and changes thereto with 
metabolite concentration were investigated in myocytes expressing either of the two isoforms 
of myosin heavy chain (α-MyHC and β-MyHC), that show altered expression in response to 
chronic ischemia.  Studies reported here demonstrate differential response to metabolites 
with Pi and H+ alone and together decreasing power generating capacity of α-MyHC while 
only in combination did they diminished β-MyHC myocyte power.  The greater tolerance 
toward ischemic conditions in β-MyHC myocytes was attributed to a Pi and H+ induced 
increase in the velocity of loaded shortening.   
 
Pi-induced changes in contractile properties of α-MyHC myocytes were more 
thoroughly assessed to probe the cross-bridge states that tend to limit power output at 
intermediate loads where muscles perform work.  Power near isometric loads is most likely 
determined by the balance between attachment and detachment of force-generating cross-
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bridges that limit isometric force, while power near maximum velocity is most likely limited 
by detachment of compressively strained cross-bridges that oppose shortening.  Addition of 
Pi had no effect on maximal shortening velocity but progressively increased velocity at all 
loads greater than ~10% isometric.  This increase in loaded shortening velocity resulted in 
increased normalized power at the corresponding loads (i.e., 10-100% isometric).  These 
results indicate cross-bridge steps associated with force-generation are most important in 
determining power output at intermediate loads where muscles operate in vivo.   
 
In contrast to ischemia, changes following exercise training are thought to improve 
cardiac function.  A pig model of exercise training was examined to determine if changes 
intrinsic to the myofilaments were partially responsible for changes in global cardiac 
function.  Increased peak power generating capacity was observed in myocytes from exercise 
trained animals as compared to sedentary controls.  The increased power output of myocytes 
from exercise trained pigs coincided with an increase in PKA-induced phosphorylation of 
myofibrillar proteins, which may partially explain increased power.  Overall, these results 
provide evidence for myofibrillar mechanisms that, in part, underlie changes in myocardial 
performance associated with acute and chronic ventricular stress.   
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Chapter 1.                                            INTRODUCTION 
 
1.1 Cardiac Structure and Function 
 
 The heart is an organ whose primary function is to move blood; it does so by forming 
a hollow opening surrounded by striated muscle.  Gross morphology of the mammalian heart 
(Figure 1.1) displays two atria and two ventricles primarily composed of myocardial tissue 
and vascularized by the coronary vessels.  The chambers pump blood by utilizing a sequence 
of relaxation and contraction known as the cardiac cycle.  The cardiac cycle consists of four 
phases:  ventricular filling, isovolumic contraction, ejection and isovolumic relaxation.  The 
cardiac cycle is well illustrated by a left ventricular volume-pressure relationship shown in 
Figure 1.1.  Left ventricular filling occurs when the pressure in the left atrium exceeds the 
pressure in the ventricle, which opens the atrioventricular (A-V) valve allowing blood flow 
from the atria into the ventricle.  During this phase the volume of blood in the ventricle rises 
with little change in ventricular pressure (Figure 1.1).  Upon electrical stimulation the 
ventricular myocardium contracts causing ventricular pressure to increase above that in the 
atria, thereby closing the A-V valve.  During this phase (i.e., isovolumic contraction) left 
ventricular pressure rises rapidly with no change in volume as both the A-V and semilunar 
valves are closed.  When ventricular pressure rises above aortic impedance the aortic valve 
opens and blood is expelled from the left ventricle into the aorta.  During this ejection phase 
the ventricle shortens against the load of blood in the aorta, which is determined in large part 
by the arterial resistance.  The ventricle then begin to relax and pressure declines.  When 
Figure 1.1 
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pressure falls below that in the aorta the semilunar valve closes and left ventricular pressure 
falls with no change in volume as both the semilunar and A-V valves are closed.  The 
differences in ventricular volume between the end of diastole and the end of systole is termed 
stroke volume (SV).  The total amount of blood pumped by the heart over a period of time is 
known as cardiac output (CO), which is the product of SV and heart rate (HR).  Because 
cardiac output appears to be exquisitely matched to the systemic demand for blood, 
concordant changes in CO and systemic demand are accomplished by either altering HR or 
SV.  Both HR and SV are tightly regulated by several mechanisms.  HR is primarily 
controlled by the autonomic nervous system (ANS) via dual innervation.  Parasympathetic 
input from the vagus nerve slows heart rate via the terminal neurotransmitter acetylcholine 
(ACh), while sympathetic input increases heart rate with the use of norepinephrine (NE).  In 
addition, HR also may be increased by epinephrine (EPI) which is released by the adrenal 
medulla and transported to the heart via the blood.  Alternatively, as all myocytes are 
activated during a heartbeat, SV is regulated by factors intrinsic to individual myocytes.  For 
example, changes in myocyte length, intracellular Ca2+ concentrations ([Ca2+]i), 
phosphorylation status of myofibrillar proteins, and ionic milieu all appear to modulate the 
force-generating capacity of individual myocytes and thus the workload and SV of the 
ventricle.  Regulation of contractile function at the level of the cardiac myocyte is the 
primary focus of this dissertation.  The studies of this dissertation examine how acute 
changes in the ionic environment associated with ischemia as well as chronic stress levels 
induced by exercise training modulate myocyte function, which ultimately modulate SV.  
The overall hypothesis put forth is that force-generating transitions are most important in 
determining power output generated by cardiac myofibrils.   
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1.2 Myocardial Structure and Function 
 
The myocardium is made up of single cardiac myocytes interconnected mechanically 
by intercalated discs and electrically by gap junctions (Figure 1.2).  Cardiac myocytes like all 
striated muscle cells consist of myofibrils, mitochondria, sarcoplasmic reticulum, nuclei and 
other cytosolic constituents (Figure 1.2) with myofibrils and mitochondria comprising greater 
than 80% of all cellular components (15).  Myofibrils are arranged in a longitudinal fashion 
with alternating light and dark regions creating a striated appearance.  These light and dark 
bands are the result of highly structured arrays of thick and thin filaments (63) (Figure 1.2).  
The light regions, or I bands, contain thin filament proteins from neighboring sarcomeres 
connected at the Z-line.  The dark regions, or A bands, contain thick filaments that are 
overlapped with thin filaments except in the H zone, which consists of thick filaments only.  
The amount of overlap between thick and thin filaments is determined primarily by the 
length of the sarcomere, which is defined as the region between two Z-lines.  Sarcomere 
length (SL), and its consequent changes in filament overlap, is one important modulator of 
myocyte function.  Thus, extreme care must be taken in controlling this variable (i.e., SL) 
during experiments examining myocyte function.  The studies in this dissertation used a 
permeabilized or skinned myocyte preparation in which SL was closely monitored during all 
mechanical measurements. 
Figure 1.2 
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  Regarding the filaments, the thin filament consists of two actin filaments in a double 
helical array, which are connected at the Z-lines of sarcomeres (Figure 1.3).  Along with 
actin, thin filaments contain tropomyosin (Tm) and troponin (Tn), the latter consists of three 
subunits, TnC, TnI, and TnT.  The Tm strand is a dimer in a coiled coil arrangement that 
binds seven actins and its position along the actin filament plays an important role in 
regulating contraction.  For instance, in the absence of Ca2+ myofilaments are in a relaxed 
state as Tm blocks the cross-bridge binding sites on actin (81, 166).  Binding of Ca2+ changes 
myofilaments to an activated state by initiating Tm movement away from the cross-bridge 
binding site of the actin strand, thereby releasing the steric blocking (81, 166).  The Tn 
complex resides in close proximity to Tm with one Tn binding for one Tm strand, that covers 
seven actin monomers; this makes up a thin filament functional unit.  Tn is comprised of 
three subunits termed TnC, TnT and TnI.  The cardiac TnC subunit contains three Ca2+ 
binding sites, two bind Ca2+ or Mg2+ with high affinity and one binds Ca2+ with low affinity 
(61).  Binding of Ca2+ to the low affinity site produces conformational changes in TnI and 
TnT that initiate the movement of Tm permitting actin and myosin interaction (61).  The TnI 
subunit forms a complex with both actin and TnC and inhibits actin-activated ATPase when 
Ca2+ is not present.  Ca2+ binding to TnC appears to increase TnC-TnI interaction strength 
and remove inhibitory effects of TnI on ATPase activity and cross-bridge cycling (114).  In 
addition, cardiac TnI contains phosphorylation sites (serines 22 and 23) for cAMP-dependent 
protein kinase (PKA) and Ca2+ -activated protein kinase (PKC) (serines 43 and 45, and 
threonine 144).   β-adrenergic stimulation yields PKA-induced phosphorylation of TnI (134) 
that modulates cardiac function by reducing the Ca2+ affinity for TnC as well as reducing the  
 Tn
I
Tr
op
om
yo
si
n M
yB
P-
C
LM
M
H
M
M
rL
C
eL
C
S1eL
C
eL
C
eL
C
A
ct
in
Tn
C
Tn
T
Fi
gu
re
 1
.3
Tn
I
Tr
op
om
yo
si
n M
yB
P-
C
LM
M
H
M
M
rL
C
eL
C
S1eL
C
eL
C
eL
C
A
ct
in
Tn
C
Tn
T
Fi
gu
re
 1
.3
  7
  8
cooperative binding of TnI to actin-Tm causing a reduction in relaxation time (71, 135).  In 
addition, several studies have suggested that PKA-induced phosphorylation also speeds  
cross-bridge cycling kinetics.  For instance, the β-agonist isoproterenol was shown to 
increase Ca2+-activated actomyosin ATPase activity in vitro (162).  In addition, β-adrenergic 
stimulation was found to increase the frequency for minimum stiffness (fmin) in intact 
papillary muscles during barium contractures (8, 60) and PKA was found to increase loaded 
shortening velocity in rat skinned cardiac myocytes during both maximal and submaximal 
Ca2+ activations (52), implying an increase in cross-bridge cycling rates during loaded 
contractions.  In agreement with loaded shortening and power being altered, a recent study 
reported that left ventricular power output was enhanced in mouse hearts expressing a 
mutated TnI that mimics constitutive bis-phosphorylation of TnI by PKA (145).  Moreover, 
β-adrenergic stimulation augmented contractility more in control than in transgenic mouse 
hearts expressing slow skeletal TnI, (which is not phosphorylated by PKA), but only during 
ejecting contractions and not during isovolumic contractions (80).  These results imply that 
PKA induced phosphorylation plays its most important role in modulating cross-bridge 
interaction during loaded contractions.   
 
The thick filaments are composed primarily of myosin.  Myosin is a large molecule 
with a long tail and two globular heads (Figure 1.3).  It can be separated into two sets of 
heavy chains (MyHC) and their two respective light chains, an essential (MLC1) and a 
regulatory (MLC2) light chain.  Application of a proteolytic enzyme, such as trypsin, divides 
the myosin molecule into two sections termed light meromyosin (LMM) and heavy 
meromyosin (HMM).  LMM is the smaller fragment of the two and comprises the tail region 
  9
of the molecule whose main purpose is thought to be maintenance of thick filament rigidity.  
Alternatively, HMM contains the S2 and S1 portions of the myosin molecule obtained with 
papain digestion, with the S1 fragment containing the neck and globular head region.  The 
light chains are located toward the neck region of S1 (Figure 1.3) and help to stabilize the 
neck and may confer some regulation of functional activity (149), such as increasing Ca2+-
sensitivity of force (138) and the rate of force development (143).  However, it is the globular 
head region of the HMM fragment that contains the exclusive ability to hydrolyze ATP and 
bind actin.  Myosin hydrolysis of the terminal phosphate on ATP is thought to provide the 
energy for binding to actin and drive muscle contraction through conformational cycles of 
myosin cross-bridges.  In mammalian ventricles there are three myosin isoforms expressed, 
composed of either a homo or heterodimer of the two MyHC isoforms, V1 (which has two α-
MyHCs), V2 (a heterodimer consisting of an α-MyHC and β-MyHC), and V3 (containing two 
β-MyHCs).  The two MyHC isoforms are individual gene products from the same 
chromosome (14, in humans) exhibiting 93% amino acid sequence homology (88).  Even 
though highly homologous, examination of the amino acid sequence reveals several regions 
of difference.  These include limited regions of the myosin head near the ATP-binding site 
(known as loop 1) and near the actin-binding site (loop 2), the α-helix in the neck region, the 
hinge between S2 and LMM, and the rod potion of LMM (88).  It is unknown how these 
variations in MyHC structure produce robust functional differences including 2-3 fold 
differences in myofibrillar ATPase activities (117, 129), rates of force development (40, 93, 
118, 123), unloaded shortening velocities (105, 130) and power outputs (51, 72).   
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The thick filament also contains myosin binding protein C (MyBP-C).  MyBP-C is 
localized to the middle two-thirds of each half sarcomere.  MyBP-C is a U-shaped molecule 
that can form trimers that are thought to wrap around the thick filament.  The trimers are 
spaced at 14.2 nm repeats, which coincides with spacing patterns of myosin heads (160).  
Also, MyBP-C contains three phosphorylation sites available for either PKA or PKC that are 
thought to modulate molecular arrangement.  Although the exact role of MyBP-C in muscle 
is not fully understood, it has been postulated that MyBP-C plays both functional and 
structural roles.  Functionally, it has been shown that the presence of MyBP-C can alter Ca2+-
sensitivity of force in a PKA dependent manner, with increased PKA-induced 
phosphorylation decreasing Ca2+-sensitivity of force (75).  Additionally, gene targeted 
deletion of cardiac MyBP-C yielded myocytes with faster rates of force development and 
greater power output (73).  These functional effects are thought to involve the interactions 
between MyBP-C and the S2 portion of MyHC.  MyBP-C has been shown to bind to the S2 
segment of myosin near the lever arm domain of the myosin head and this interaction is 
thought to be altered by PKA-induced phosphorylation (44, 47).  Theoretically, MyBP-C 
binding to S2 may keep the myosin heads closer to the thick filament backbone limiting the 
range of movement thereby decreasing the probability of myosin binding actin.  It follows 
then that MyBP-C extraction, truncation, or phosphorylation may create cross-bridges less 
constrained with a greater probability of binding to actin.  In addition to functional duties, the 
binding of MyBP-C to S2 and possibly titin is thought to play a structural role in sarcomeric 
assembly as well.  Mutations in the MyBP-C gene generating truncated proteins with lesser 
binding to MyHC result in disarrangement of structure at the myofilaments (168).  
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Additionally, dephosphorylation of MyBP-C that can occur with ischemia can produce 
similar sarcomere disarrangement (24). 
 
1.3 Actomyosin interaction: Cross-bridge cycling 
 
          During muscle contraction myosin cross-bridges cyclically interact with actin in a 
process that is driven enzymatically by ATP hydrolysis.  The chemomechanical states in the 
cross-bridge cycle have been studied extensively in skinned muscle fiber preparations and the 
transition rates between these states are qualitatively similar to rates derived from muscle 
protein studies in solution (46).  A current model of the chemomechanical steps in cross-
bridge cycle is provided in figure 1.4 with rate constants for some defined steps.  
Importantly, these rate constants reflect values obtained in psoas muscle fibers at 20° C under 
isometric conditions.  As the cross-bridge cycle represents a series of enzymatic steps that are 
influenced by experimental conditions, changes in conditions certainly may alter rates.  In 
fact, the kinetics of the cross-bridge transitions have been shown to depend on such things as 
velocity of muscle shortening (i.e., strain dependence) and temperature and furthermore these 
strain and temperature dependences appear to vary among transition steps (33, 172).  For 
example, rate of ATP utilization is largely strain dependent, with utilization increasing with 
velocity of shortening (33), while ATP hydrolysis is primarily strain independent (34).  In 
addition, force generating states are greatly affected by changes in temperature, while ATP 
binding is only minimally altered (172). 
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          According to the cross-bridge model, actin and myosin are very tightly bound (i.e., in 
the rigor state) in the absence of nucleotide (i.e., the AM state). The binding of ATP to the 
nucleotide binding cleft of myosin (with has a second order rate constant of 106 M-1· s-1) (14) 
decreases the affinity of myosin for actin, and causes rapid detachment of  
the myosin head (step 1).  The unattached or weakly attached myosin head then hydrolyzes 
ATP into ADP and Pi at a rate of 100 s-1 (84).  ATP hydrolysis is associated with a change in 
myosin formation to a more compact structure (55).  Hypothetically this change in structure 
corresponds to a “repriming” of the cross-bridge from a post-powerstroke formation to one 
ready and able to move through force-generating steps.  Myosin heads with either ATP or 
ATP hydrolysis products bound exist in equilbrium between weakly bound or unbound states 
(13), as indicated in Figure 1.4.  The weakly bound state with a full compliment of nucleotide 
products is thought to occur only transiently in intact fibers while moving into a strongly 
bound state having the same products (step 3) (13).  Though a strongly bound, non-force 
generating state is indicated in Figure 1.4, evidence for this state is limited as it again is 
likely a very transient state.  However, a weak to strong binding step has been postulated to 
be the step regulated by Ca2+ (84).  Following this, an isomerization of the strongly bound 
state (having ADP and Pi bound) is thought to occur producing force (step 4) (4, 42, 156).  
This isomerization utilizes a structural change characterized by attached heads becoming 
more ordered in the catalytic domain (7) and rotation of the neck region of the myosin 
molecule (65).  In addition, evidence suggests a proton (H+) is lost in this transition from a 
weakly to strongly bound force-generating state (1).  This step containing the isomerization is 
considered the fundamental force-generating step or powerstroke of the cross-bridge cycle.  
The release of Pi is closely related to the force-generating isomerization, with Pi release 
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potentially stabilizes the structure (step 5) (20).  The rate of movements through steps 4 and 5 
(isomerization and Pi release) are difficult to separate experimentally; though step 5 is at least 
40 s-1 (50).  Finally, an irreversible isomerization occurs with ADP release following closely 
behind (54).  Further movement of the cross-bridge is thought to occur during this step 
leaving cross-bridges in rigor-like formations (67).  This later isomerization and product 
release have been proposed to be the rate-limiting step in isometric contractions having a rate 
constant of 5-25 s-1 (20, 56).  Force generation beginning at step 4 is maintained following Pi 
release (step 5) and the isomerization coupled to ADP release (step 6), with the AM*ADP+Pi 
(which is reversible) and AM*ADP (which is irreversible) the largest populations of cross-
bridges during isometric contraction (42).  Interestingly, addition of Pi to active muscle 
inhibits force by 50-70% (69, 109) indicating that of force-generating cross-bridges only a 
small proportion are in force-generating states beyond the irreversible isomerization 
associated with ADP release.  Furthermore, the observation that addition of physiological 
concentrations of Pi can inhibit force indicate that this transition (step 5) is not associated 
with a large drop in free energy, making it highly reversible (16, 20).  Binding of ATP and 
subsequent cross-bridge detachment follow and thus the cycle repeats itself.   
 
As just described, force is generated by cross-bridge rearrangement performing a so 
called powerstroke.  The amount of force generated depends upon the number of cross-
bridges in these states (steps 4-6).  In addition to generating force the powerstroke can move 
the thin filament in the opposite direction of the thick filament (i.e. thin filaments are 
propelled toward the middle of the sarcomere).  Shortening occurs if the load that cross-
bridges are cycling against is less than the maximum force that can be generated by the given 
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number of cross-bridges bound.  The load dependence of shortening manifests as an inverse 
relationship between force and velocity of sarcomere shortening (Figure 2.4).  The point at 
which the load is so high that no shortening occurs indicates maximal isometric force (the 
interception of the x (force)-axis).  Isometric force is ultimately determined by the number of 
force-generating cross-bridges, and is limited by the balance between the rates of force-
generating transitions and detachment of positively strained cross-bridges (63).  Conversely, 
the y(velocity)-intercept of the force-velocity relationship represents cross-bridges cycling 
against essentially no load.  As velocity increases toward this point, shortening is likely 
limited by cross-bridge detachment rates because cross-bridges that remain bound become an 
internal load that opposes shortening as filaments slide past each other.  Thus, the speed of 
unloaded shortening reaches its limit when negative resistance forces equal positive forces 
(63).  However, it is unknown which chemomechanical transitions are most important in 
determining force and shortening speeds at intermediate loads where myocytes produce 
optimal power output.  As elevations in [Pi] (from 0 to ~15 mM) increase the rate of force 
development (4, 53, 147, 151) but have no effect on unloaded shortening velocity in skinned 
fast-twitch skeletal muscle fibers (17, 158), experiments in the presence of increased [Pi] 
should indicate at which loads shortening velocities are most influenced by Pi transitional 
states, i.e., those which are associated with strong-binding to force producing states (steps 3 
to 5).  Thus, investigation of the effects of elevated [Pi] on loaded shortening and power 
output in cardiac myocytes provides mechanistic insights into the transitions that are most 
important in determining power output in cardiac myocytes, with particular interest in loads 
where power output is optimal since these are the loads that in vivo myocytes are thought to 
encounter during the ejection phase of the cardiac cycle. 
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1.4 Cardiac function during Ischemia 
 
Low coronary blood flow can produce cardiac stress and lead to large changes in the 
pump performance of the ventricle.  For example, patients with coronary artery disease 
demonstrate reduced left ventricular function as indexed by decreased ejection fraction and 
cardiac output (98).  Echocardiography (144) and three-dimensional MRI (100)  determined 
that global decreases in function are the likely result of regional dysfunction created by 
abnormally contracting segments of the myocardial wall.  Therefore chronic ischemia has the 
ability to produce segmental abnormalities creating global dysfunction and acute coronary 
ligation can produce similar results.  For instance, acute reduction of regional blood flow by 
coronary ligation decreased segmental shortening in open-chest pigs within the first 15 heart 
beats, resulting in a significant fall of left ventricular systolic pressure and rates of pressure 
development (3).  In addition, Langendorff-perfused working heart preparations displayed 
rapid declines in developed pressure and slowed rates of pressure decline (157).  The 
mechanisms for functional changes such as described above are proposed to include (but not 
limited to): decreased intracellular [ATP], decreased Ca2+ availability, decreased pH, lowered 
free energy of ATP hydrolysis, and increased [Pi].  The actual mechanisms producing 
dysfunction are most likely dependent upon many factors such as duration or severity of 
ischemia or the experimental model being studied.  Further evaluation of the mechanisms 
responsible for changes in myocardial function during early acute ischemia have been 
provided by studies utilizing nuclear magnetic resonance (NMR) spectroscopy in 
combination with functional measurements.  One such study measured decreased segmental 
shortening in an open-chest pig model of graded ischemia that correlates with decreased pH 
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and increased Pi (127).  A subsequent study using working heart preparations showed little 
change in [ATP], free energy of ATP hydrolysis, and Ca2+ transients with decreased pressure 
generation during moderate ischemia (35).  In this study [Pi] and pH were again found to 
decrease in relation to diminishing function (35).  Of interest is the fact that in this study, 
pressure changes during ischemia occurred in the presence of similar [Ca2+] indicating a 
potential desensitization of the contractile apparatus to Ca2+.  Once again increased [Pi]and 
[H+] provide potential mechanisms for this functional observation as it has been reported that 
both Pi and H+ decrease Ca2+ sensitivity of force in skinned cardiac muscle preparations (43, 
165).  These studies and others have utilized skinned preparations to examine the effects of Pi 
and H+ on contractile properties of muscle.  For example, both Pi and H+ decrease ATPase 
activity in skinned rat trabeculae however, they do so to a lesser extent than their effect on 
maximal Ca2+-activated force (27).  Also, H+ has been reported to slow Vo in cardiac muscle 
strips (120), whereas Pi has no effect on skeletal fibers at low concentrations (<15mM) (17, 
89, 158) and a small slowing effect at very high concentrations (>50mM) in skeletal muscle 
fibers (17).  Because measurements of maximum shortening velocity, Ca2+-sensitivity of 
force and maximal force production provide some important information concerning the 
effects of Pi and H+ on myocardial contractile properties during ischemia, they do not address 
directly how these factors modulate rates of force development and rates of loaded 
shortening, which more closely assess how myocytes perform during isovolumic contraction 
and ejection phases of the cardiac cycle.  The following work directly examined the effects of 
Pi and H+ on rates of force redevelopment, loaded shortening, and power output in rat 
skinned cardiac myocytes.   
 
  18
When examining the effects of ischemia on the myocardium it is important to 
recognize that many factors including contractile protein isoform expression may contribute 
to the functional response.  Studies using skinned skeletal fibers have reported lesser 
depressant effect of Pi (103, 147) or H+ (91) on force in slow-twitch fibers than in fast-twitch 
fibers.  This may be especially significant in mammalian hearts as MyHC isoform changes 
toward β-MyHC isoform (which is the same isoform as in slow-twitch fibers) following 
prolonged ischemia, infarction, and during heart failure (119, 167, 169).  The potential 
differential effects of ischemic metabolites on power output of cardiac myocytes have not 
been previously examined even though a switch towards a more resistant isoform would 
appear to be advantageous teleologically in situations of ischemic heart disease.  Thus, we 
examined the effects of increased metabolite concentrations on force, loaded shortening 
velocity and power output of single skinned cardiac myocytes primarily expressing either α- 
or β-MyHC.  For these studies permeabilized myocyte preparations were used.  These 
preparations offer several advantages including 1) control of intracellular ionic composition 
and substrates, 2) control of sarcomere length, and 3) assessment of MyHC composition on 
the same preparation that functional measurements were performed.  
 
1.5 Cardiac function with chronic exercise 
 
 
 During exercise the heart matches increased tissue demand for blood by increasing 
cardiac output.  This is accomplished acutely by increasing HR and SV (124).  Upon the start 
of exercise there is increased sympathetic outflow, which activates β-adrenergic receptors 
leading to an increase in heart rate, shortening of the refractory period, and enhancement of 
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myocardial contractility.  Following chronic exercise training, a myriad of changes occur that 
increase cardiac contractility such that smaller increases in HR are needed to accommodate 
elevations in systemic demand at a given workload (128).  Many mechanisms could be 
responsible for such results, though, they most likely vary dependent upon exercise type, 
duration and intensity.   
 
Increased stroke volume is thought to be due, in part, to training-induced alterations 
of the intrinsic contractile function of the myocardium (36, 66, 68, 95).  Alterations of 
contractile function following exercise have primarily been limited to measurements of either 
force production or unloaded shortening velocity.  While only a few studies have focused on 
the effects of exercise training on the entire force-velocity relationship as it is velocity of 
shortening under a load that is most applicable to in vivo function  (121).  Two studies 
utilizing a rat model of chronic exercise training reported increased velocity of shortening for 
a given load in myocardial preparations from trained animals (25, 95).  However, alterations 
in loaded shortening have not been investigated in other animal models, specifically larger 
animal models such as swine that may more closely mimic human physiology.  The purpose 
of the study presented here was to evaluate a pig model of exercise training for mechanical 
changes intrinsic to the myofilaments.  The use of a porcine model of exercise training to 
investigate physiological changes that occur in large mammals may be applicable to humans 
as pigs and humans have similar heart morphology and similar adaptive responses to chronic 
exercise with respect to maximal oxygen consumption (VO2max), SV, HR and skeletal 
muscle oxidation capacity (for review see (87)).  This model has previously been shown to 
produce increased exercise tolerance, moderate cardiac hypertrophy, increased coronary 
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blood flow capacity, increased oxidative capacity of skeletal muscle and lower heart rates 
during exercise at submaximal intensities (77).  These changes occurred without alterations 
in myofibrillar ATPase, Ca2+ regulatory systems, or the metabolic system (77).  However, 
SV was increased at submaximal workloads (77).   
 
Greater SV following exercise training could be the result of a number of things 
including greater ventricular volume, less aortic resistance or greater myocardial 
contractility.  Multiple structural and functional adaptations within the heart could be 
responsible for such changes, such as:  myocardial hypertrophy, changes in Ca2+ handling, 
altered myofibrillar protein expression and covalent modification of myofibrillar proteins (as 
reviewed(96)).  Alterations in myocyte morphology may contribute to enhanced contractility.  
For example, myocyte hypertrophy occurring with endurance training can increase the 
tension-generating capacity of cardiac muscle (101, 148).  As opposed to changes in width, 
changes in length have also been reported following exercise training (68, 97).  Greater cell 
length contributes to enlargement of the ventricular chamber allowing greater ventricular 
filling.  Additionally, changes to Ca2+ handling with exercise training have been reported.  
Data from experiments measuring Ca2+ transients and sensitivity have been mixed, with a 
few studies reporting an increase in myofilament Ca2+ sensitivity (26, 68, 163) while others 
have seen no difference in sensitivities (101) or Ca2+ transients (79, 163) in ventricular 
myocytes from exercise trained as compared to sedentary control rats.  As opposed to 
myocyte size or Ca2+ handling, changes in myofibrillar protein content also occur following 
exercise training.  Shifts toward greater α-MyHC content have been reported in multiple 
endurance exercise training models (9, 49, 66).  Greater α-MyHC content increases the rate 
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of force redevelopment following a mechanical perturbation (ktr) in cardiac muscle 
preparations (40).  And, while maximal Ca2+-activated force is not different between α- and 
β-MyHC myocytes, power generating capacity is about three times higher in α-MyHC 
myocytes and working heart preparations (72).  Increased ktr or loaded shortening would 
enhance contractility thus providing a potential molecular mechanism for the exercise 
induced enhancement of SV.  In addition to MyHC, cardiac TnT (cTnT) protein isoform 
expression was recently found to be altered in a pig model of diabetes and exercise (74).  
Moreover, cTnT isoform expression correlated with fractional shortening, whereby higher 
levels of the larger isoforms were found in heart that had greater function (74).  Furthermore 
changes in cTnT isoform content occur in humans during the progression to heart failure (6) 
further indicating a potential causative role in functional changes.  Finally, sympathetic 
innervation increases during exercise, increasing β-adrenergic activity of the heart.  In 
cardiac myocytes the response pathway includes β-adrenergic receptor activation of 
adenylate cyclase (AC) and increased intracellular concentrations of cAMP.   Basal and peak 
AC activities increase in young and aged rats following treadmill exercise training (11, 126).  
Higher levels of cAMP allow increased PKA activity.  As discussed previously, PKA-
induced phosphorylation of cTnI and MyBP-C increase myofibrillar functional capacity by 
increasing the rate of force development (110) and loaded shortening velocity causing the 
production of greater power output (52).  The main objective of this study was to determine 
if myocardial contractility differs from sedentary (SED) and exercise trained (EX) pig 
myocytes as indexed by isometric force, loaded shortening velocity, power output and rate of 
force development during maximal Ca2+ activation.  Another objective of the study presented 
here was to determine if alterations in cardiac myofibrillar proteins may account for any 
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functional differences observed.  Specifically, we examined relative MyHC content, relative 
cardiac cTnT isoform content, and PKA-induced baseline phosphorylation of the myofibrillar 
proteins cardiac cTnI and MyBP-C. 
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Chapter 2.      INORGANIC PHOSPHATE SPEEDS LOADED SHORTENING 
IN RAT SKINNED CARDIAC MYOCYTES. 
 
 
ABSTRACT 
 
Force generation in striated muscle is coupled with inorganic phosphate (Pi) release 
from myosin, because force falls with increasing [Pi].  However, it is unclear which cross-
bridge transitional states limit loaded shortening and power output.  We examined the role 
that Pi plays in determining force, unloaded shortening, loaded shortening, power output, and 
rate of force development in rat skinned cardiac myocytes.  Myocytes (n =6) were attached 
between a force transducer and position motor and contractile properties were measured over 
a range of loads during maximal Ca2+ activation.  Addition of 5mM Pi had no effect on 
maximal unloaded shortening velocity Vo (Control Vo = 1.83 ± 0.75; 5mM added Pi Vo = 
1.75 ± 0.58 ML/sec, n =6).  Conversely, addition of 2.5, 5, and 10 mM Pi progressively 
decreased force but resulted in faster loaded shortening and greater power output (when 
normalized for the decrease in force) at all loads greater than ~15% isometric force.  Peak 
normalized power output increased 16% with 2.5 mM added Pi and further increased to a 
plateau of ~35% with 5 and 10 mM added Pi.  Interestingly, the rate constant (ktr) of force 
redevelopment progressively increased from 0 to 10 mM added [Pi] with ktr being ~360% 
greater at 10mM than 0 mM added [Pi].  Overall, these results suggest that the Pi release step 
in the cross-bridge cycle is rate-limiting step for determining shortening velocity and power 
output at intermediate and high relative loads in cardiac myocytes.   
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INTRODUCTION 
During muscle contraction myosin cross-bridges cyclically interact with actin in a 
process that is driven energetically by hydrolysis of ATP.  The chemomechanical states in 
the cross-bridge cycle have been investigated extensively in skinned muscle fiber 
preparations and the transition rates between these states are qualitatively similar to rates 
derived from muscle protein studies in solution (46).  A working model for the 
chemomechanical steps in the cross-bridge cycle is shown in Figure 1.4 (153), that is based 
on extensive work in the field (for reviews see (16) and (46)).  
 
 According to this model, the transition from weak-binding, non-force generating 
cross-bridges to strong-binding, force generating states is associated with the release of Pi 
(steps 3-5) (53).  Force generation is maintained through the release of ADP (step 6) (21, 83), 
which is followed by binding ATP and subsequent cross-bridge detachment.  The binding of 
ATP and its hydrolysis are thought to be relatively fast processes in skinned fibers (34, 45, 
84).  Thus, the rate limiting step in the cross-bridge cycle is thought to occur following ATP 
hydrolysis, either during an isomerization of the AM ADP Pi state (step 3), which is 
associated with the weak to strong binding transition, or an isomerization step of the AM 
ADP state just prior to ADP release (i.e., step 6) and cross-bridge detachment (for reviews 
see (16) and (46)).  Another factor in this cross-bridge schematic is the fact that transition 
rates vary as a function of load on the muscle, becoming faster as muscle load is reduced.  
For instance, the rate constant of force decline (kPi) following rapid increase in solution Pi 
varied linearly as a function of load (62).  Thus, the rate limiting steps may be different as the 
load on the myofilaments changes.  For instance, unloaded muscle shortening is likely 
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limited by cross-bridge detachment rates, because cross-bridges that remain bound ultimately 
become an internal load as filaments slide past each other.  Thus, the speed of shortening of 
an unloaded muscle is thought to reach its limit when compressive resistance forces equal 
positive forces (63).  At the other intercept of the force-velocity curve, isometric force is 
ultimately determined by the number of force-generating cross-bridges, which is limited by 
the balance between the rates of force-generating transitions and detachment of positively 
strained cross-bridges.  It is unknown which chemomechanical transitions are most important 
in determining force and shortening speeds and, thus, power output at intermediate loads 
where muscles perform work.  As elevations in [Pi] (from 0 to ~15 mM) increase the rate of 
force development (4, 53, 147, 151); but have no effect on unloaded shortening velocity in 
skinned fast-twitch skeletal muscle fibers (17, 89, 158), experiments in the presence of 
increased [Pi] should indicate at which loads shortening velocities are most influenced by Pi 
transitional states, i.e., those which are associated with weak to strong-binding to force 
producing states (steps 3 to 5).  Thus, we investigated the effects of elevated [Pi] on loaded 
shortening and power output in permeabilized single cardiac myocytes in order to gain 
mechanistic insights into the cross-bridge steps that are most important in determining power 
output in cardiac myocytes, with particular interest in loads where power output is optimal as 
these are the loads that in vivo myocytes are thought to encounter during the ejection phase of 
the cardiac cycle. 
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METHODS 
Cardiac myocyte preparation 
Normal Sprague-Dawley rats were obtained from Harlan (Madison, WI), maintained, 
and humanely killed according to guidelines set by the Animal Care and Use Committee of 
the University of Missouri.  Single skinned cardiac myocytes were obtained by mechanical 
disruption of hearts as described previously (85).  Rats were anaesthetized by inhalation of 
isoflurane (0.05 mg) for 2-4 minutes in an airtight one-liter container and their hearts were 
excised and rapidly placed in ice cold relaxing solution.  The ventricles were dissected away 
from the atria, cut into 2-3 mm pieces and further disrupted for 5-10 seconds in a Waring 
blender.  The resulting suspension of cells was centrifuged for 65 sec at 165 x g, after which 
the supernatant fluid was discarded.  The myocytes were skinned by suspending the pellet of 
cells for 3 min in 0.5 % ultrapure Triton X-100 (Pierce Chemical Co.) in relaxing solution.  
The skinned cells were washed twice with cold relaxing solution, resuspended in 10-15 ml of 
relaxing solution and kept on ice during the day of the experiment.  Myocytes were used 
within 12 hours of isolation. 
 
Solutions 
Relaxing solution in which the ventricles were disrupted, skinned, and suspended 
contained (in mmol/L): EGTA 2, MgCl2 5, ATP 4, imidazole 10, and KCl 100 at pH 7.0.  
Compositions of relaxing and activating solutions used in mechanical measurements were as 
follows (mmol/L):  EGTA 7, free Mg2+ 1, imidazole 20, MgATP 4, creatine phosphate 14.5, 
pH 7.0, Ca2+ concentrations of 10-9 M (relaxing solution) and 10-4.5 M (maximal activating 
solution), and sufficient KCl to adjust ionic strength to 180 mM.  Activating solutions used in 
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phosphate experiments were identical to those described above except for inclusion of 2.5, 5 
and 10 mM concentrations of potassium phosphate (KH2PO4) before adjustment to ionic 
strength of 180 mM.  The final concentrations of each metal, ligand and metal-ligand 
complex at 13°C were determined with a computer program (31).  Immediately preceding 
activations, muscle preparations were immersed for 60 s in a solution of reduced Ca2+-EGTA 
buffering capacity, identical to normal relaxing solution except that EGTA is reduced to 0.5 
mM.  This protocol resulted in more rapid steady state force development and helped 
preserve the striation pattern during activation.   
 
Experimental Apparatus  
 The experimental apparatus for physiological measurements of myocyte preparations 
was similar to one previously described in detail (99) and modified specifically for cardiac 
myocyte preparations (85).  Briefly, myocyte preparations were attached between a force 
transducer and torque motor by gently placing the ends of the myocyte into stainless steel 
troughs (25 gauge).  The ends of the myocyte were secured by overlaying a 0.5 mm long 
piece of 3-0 monofilament nylon suture (Ethicon, Inc.) onto each end of the myocyte, and 
then tying the suture into the troughs with two loops of 10-0 monofilament suture (Ethicon, 
Inc.).  The attachment procedure was performed under a stereomicroscope (~100x 
magnification) using finely shaped forceps.       
 
Prior to mechanical measurements the experimental apparatus was mounted on the 
stage of an inverted microscope (model IX-70, Olympus Instrument Co., Japan), which 
rested on a pneumatic anti-vibration table with a cut-off frequency of ~1 Hz.  Force 
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measurements were made using a capacitance-gauge transducer (Model 403-sensitivity of 20 
mV/mg plus a x10 amplifier and resonant frequency of 600 Hz; Aurora Scientific, Inc., 
Aurora, ON, Canada).  Length changes during mechanical measurements were introduced at 
one end of the preparation using a DC torque motor (model 308, Aurora Scientific, Inc.) 
driven by voltage commands from a personal computer via a 12-bit D/A converter (AT-MIO-
16E-1, National Instruments Corp., Austin, TX, USA).  Force and length signals were 
digitized at 1 kHz using a 12-bit A/D converter and each was displayed and stored on a 
personal computer using custom software based on LabView for Windows (National 
Instruments Corp.).   
  
Images of the myocyte preparations were recorded digitally on a personal computer 
while relaxed and during activation using a Hamamatsu CCD camera (model 2400) and 
video snapshot software (Figure 1).  Videomicroscopy was completed using a 40x objective 
(Olympus UWD 40) and 25x intermediate lenses.  During and after each experiment, the 
images were reviewed to obtain sarcomere length measurements from the myocyte while 
relaxed and activated; myocyte length and width for cross-sectional area calculations also 
were obtained from these images.  Sarcomere lengths of these preparations was set to yield 
passive forces near zero.  The dimensions of the skinned cardiac myocyte preparations are 
reported in Table 2.1.   
 
Mechanical measurements 
All mechanical measurements were made at 13 ± 1°C.  Power output of single 
skinned myocyte preparations was determined at varied loads as previously described (85).  
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Briefly, myocytes were placed in activating solution and once steady-state force developed, a 
series of force clamps (less than steady-state force) were performed to determine isotonic 
shortening velocities.  Using a servo-system, force was maintained constant for a designated 
period of time (150-250 msec) while the length change was continuously monitored.  
Following the force clamp, the myocyte preparation was slackened to reduce force to near 
zero to allow estimation of the relative load sustained during isotonic shortening; the 
myocyte was subsequently re-extended to its initial length.   
 
Table 2.1.  Summary of Skinned Cardiac Myocyte Dimensions  
  Sarcomere Length 
Length (µm) Width (µm) pCa 9.0 (µm) pCa 4.5 (µm) 
131 ± 28 22.8 ± 2.6 2.36 ± 0.05 2.29 ± 0.10 
Values are means ± SD; n = 6.  
 
Isotonic shortening velocities were measured in activating solutions containing varied 
amounts of additional Pi (0, 2.5, 5 and 10 mM).  Each cell underwent a series of loaded 
contractions in each of the Pi solutions, whose order was chosen at random.  In this way each 
cell served as its own control and pairwise statistical analysis could be performed.  Isometric 
force was measured in activating solution with no additional Pi prior to and following 
measurements of isotonic shortening velocities to detect rundown of the preparation.  
Myocytes were discarded if a 20% or greater decrease in isometric tension occurred. 
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The kinetics of force redevelopment were obtained using a procedure previously 
described for skinned cardiac myocyte preparations (73).  While in Ca2+ activating solution, 
the myocyte preparation was rapidly shortened by ~15% of the myocyte’s initial length (Lo) 
to produce zero force.  The myocyte preparation was then allowed to shorten for ~20 ms; 
after 20 ms the preparation was rapidly re-stretched to ~105% of its initial length (Lo) for 2 
ms and then returned to Lo.  The slack-re-stretch maneuver caused dissociation of cross-
bridges and subsequent force redevelopment was due to reattachment of cross-bridges and 
transition to force-generating states.  Force redevelopment measurements were carried out 
prior to the series of loaded contractions at each Pi concentration. 
 
Unloaded shortening velocity (Vo) was measured during maximal Ca2+ activations 
using the slack test method (28, 140).  Once steady-state force was reached the myocyte 
preparation was rapidly (< 2 msec) slackened to a predetermined value between 5% and 20% 
of its initial length.  The time between the imposition of the slack step and the onset of force 
redevelopment was measured from the intersection of two lines fitted by eye through the zero 
force baseline and the initial phase of force redevelopment (Figure 2.3).  The length of 
release was plotted against the duration of unloaded shortening and Vo was determined from 
the slope of a line fitted to the data by linear regression analysis.    
 
Data Analysis 
 Myocyte preparation length traces were fit to a single decaying exponential equation:   
(1)                                                    L = Ae-kt + C 
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where L is cell length at time t, A and C are constants with dimensions of length, and k is the 
rate constant of shortening (kshortening).  Velocity of shortening at any given time, t, was 
determined as the slope of the tangent to the fitted curve at that time point.  In this study, 
velocities of shortening were calculated at the onset of the force clamp (i.e., t = 0). 
   
 Hyperbolic force-velocity curves were fit to the relative force-velocity data using the 
Hill equation (57): 
(2)                                          (P + a)(V + b) = (Po + a)b 
where P is force during shortening at velocity V; Po is the peak isometric force; and a and b 
are constants with dimensions of force and velocity, respectively.  Power-load curves were 
obtained by multiplying force x velocity at each load on the force-velocity curve.  The 
optimum force for mechanical power output (Fopt) was calculated using the equation (164): 
(3)                                                Fopt = (a2 + a·Po)1/2 - a 
Curve fitting was performed using a customized program written in Qbasic, as well as 
commercial software (Sigmaplot).   
 
Force redevelopment traces were fit by a single exponential function: 
F = Fmax (1 – exp(-ktrt)) + Fres, 
where F is tension at time t, Fmax is maximal tension, and ktr is the rate constant of tension 
redevelopment.  Fres represents any residual tension present immediately after the slack-
restretch maneuver. 
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Statistics 
 One–way repeated measures ANOVA were used to determine significant effects on 
force, absolute and normalized power output, and ktr from varied Pi concentrations.  The 
Student-Newman-Keuls test was used post hoc to assess the differences among means.  A 
paired t-test was used to compare Vo values before and after addition of 5 mM Pi.  p < 0.05 
was chosen as indicating significance.  Values are expressed as means ± SD unless otherwise 
indicated. 
 
RESULTS 
 The addition of Pi resulted in a progressive decrease in maximal Ca2+ activated force 
in skinned cardiac myocyte preparations.  Force declined from a control value of 21 ± 7 
kN·m-2 to 14 ± 5 kN·m-2, 12 ± 5 kN·m-2, and 7 ± 3 kN·m-2 in the presence of 2.5, 5, and 10 
mM added [Pi], respectively.  These effects of added Pi on skinned myocyte preparations 
were quantitatively similar to those from permeabilized multicellular cardiac muscle 
preparations at pH 7.0 (103).   
 
Previous studies have reported that maximal velocity of shortening (i.e., unloaded) is 
minimally affected by addition of up to 15 mM added Pi in fast-twitch skeletal muscle fibers 
(17, 89, 158).  We addressed whether Pi alters unloaded shortening velocity (Vo) in cardiac 
myocyte preparations using slack tests before and after the addition of 5 mM Pi.  Figure 2.1 
shows force traces following rapid slack steps in a cardiac myocyte preparation during 
maximal Ca2+ activation in the presence and absence of 5 mM added Pi.  Consistent with 
skeletal muscle reports, Vo was unchanged in response to added Pi in cardiac myocyte 
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preparations (Control Vo = 1.83 ± 0.75; 5 mM added Pi Vo = 1.75 ± 0.58 ML/sec).  This 
finding suggests that cross-bridge interaction transitions that limit maximal shortening 
velocity (i.e., detachment of compressively strained cross-bridges) are minimally affected by 
addition of Pi.     
 
 A main focus of this study was to examine the effects of added Pi on rates of loaded 
shortening and power output of cardiac myofibrils.  Since previous studies using skinned 
fiber preparations imply that added Pi speeds force-generating transitions (4, 94) but has no 
effect on detachment rates of compressively strained cross-bridges (see above), the addition 
of Pi would be expected to increase normalized power only at loads where loaded shortening 
is limited by force-generating transition rates.  We measured skinned myocyte shortening 
velocities over a range of loads and plotted averaged force-velocity and power-load curves in 
response to added Pi (Figure 2.2).  For these curves, force was normalized for the Pi-induced 
decrease in isometric force, which allowed direct observation of how Pi alters shortening 
velocity and power at given relative loads.  Addition of Pi sped loaded shortening and 
increased normalized power output over load ranges above ~10% isometric force.  Peak 
normalized power output increased 16% with 2.5 mM added Pi and was further elevated to a 
plateau of ~35% greater than 0 mM Pi with the addition of 5 and 10 mM (Figure 2.2).  These 
results taken together with the Vo results imply that force-generating transition rates (which 
are Pi dependent) as opposed to detachment rates (of compressively strained cross-bridges) 
determine power output over most load ranges in cardiac myocytes.  Interestingly, though, 
the increase in loaded shortening with added Pi was not great enough to offset the Pi-induced 
                                    Figure 2.1 
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Figure 2.1.  Effect of 5mM added Pi on unloaded shortening velocity (Vo) in a skinned 
myocyte preparation. 
 
A.  Length traces and force traces are shown during a slack test before and after addition of 5 
mM Pi.  Unloaded shortening times following length changes were similar before and after 
the addition of Pi.  B.  Slack plot before and after addition of Pi.  Vo for this skinned myocyte 
preparations was 1.29 ML/s before and 1.18 ML/s after the addition of 5 mM Pi.  
Additionally, in this same myocyte preparation, loaded shortening was measured and peak 
normalized power output was ~35% greater after addition of 5 mM Pi (data not shown), 
which is consistent with the results from the six myocyte preparations reported in Table 2.2. 
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Figure 2.2.  Effect of added Pi on myocyte force-velocity and power-load relationships. 
 
A.  Force-velocity and normalized power-load curves shifted upward in response to increased 
concentrations of added [Pi].  B. Absolute force-velocity and power-load curves in presence 
of 0 and 2.5 mM added Pi.  Data points are means ± SEM. 
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fall in force to maintain absolute power output (Figure 2.2).  Peak absolute power output (85 
± 12 pW, with no additional Pi) decreased 16% (71 ± 14 pW) with 2.5mM Pi added, 16% (71 
± 12 pW) with 5mM Pi and 52% (41 ± 13 pW) with 10 mM Pi.  Thus, added Pi increases  
power output at a given relative load but not at a specific absolute load due to its marked 
effect of depressing force generation capacity. 
 
 We also addressed the effects of added Pi on the rate of myocyte force development 
following a mechanical perturbation to assess the potential role of this process in determining 
loaded shortening and power output.  The rate constant of force redevelopment (ktr) increased 
in the presence of rising Pi concentrations (Figure 2.3).  ktr increased from 6.1 ± 1.4 s-1 in 
controls to 8.5 ± 1.3 s-1 in the presence of 2.5 mM Pi, representing a 40% increase from 
control.  Addition of 5 mM and 10 mM Pi further increased ktr 94% (11.8 ± 3.1 s-1) and 379% 
(28.1 ± 7.8 s-1) above control, respectively.  Interestingly, the residual force (i.e., the force 
just prior to force redevelopment) was consistently higher as added Pi increased.  Residual 
forces were 20 ± 3%, 30 ± 3%, 37 ± 4% and 47 ± 11% of isometric force at 0, 2.5, 5 and 10 
mM added Pi, respectively.  The exact reason for this is unclear but may involve faster 
transition(s) to force generating cross-bridges as a function of [Pi].  Because of this 
potentially confounding influence of residual force, we also examined the rate of force 
redevelopment following a ~10% slack step.  The rates of force development were 4.77 ± 
1.81 with no added Pi and 8.57 ± 2.30 with 5 mM Pi (p = 0.003, n = 6); this result is 
quantitatively similar to that observed with the slack re-stretch maneuver.  Overall, these 
results are quantitatively different from the Pi-induced increase in normalized power output,  
Figure 2.3 
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suggesting that cross-bridge steps that determine power output differ from the transitions that 
limit force redevelopment in cardiac muscle.        
 
DISCUSSION 
This study examined the effects of added Pi on force, unloaded shortening, loaded 
shortening, power output, and rates of force development in rat skinned cardiac myocyte 
preparations.  Addition of Pi lowered isometric force, had no effect on unloaded shortening 
velocity but increased loaded shortening, power output, and rates of force development.  The 
decrease in force exceeded the decline in peak absolute power output because of the Pi-
induced increase in loaded shortening velocity.  The increase in loaded shortening velocity  
yielded greater peak myocyte power output after normalizing for changes in isometric force.  
These results, taken together, suggest that peak power output is more determined by force-
generating steps in the cross-bridge cycle than cross-bridge detachment rates since Pi is 
known to speed force-generating transitions but appeared to have no effect on detachment of 
compressively strained cross-bridges.     
 
The effects of Pi on contractile properties have been extensively examined in both 
skinned skeletal and cardiac muscle preparations.  Interestingly, contractile properties of 
cardiac muscle preparations appear to be more sensitive to added Pi than skeletal muscle 
preparations.  For instance, Nosek et al. (103) reported that 10 mM added Pi decreased 
cardiac muscle force ~60% compared to a 40% force decline in skeletal muscle preparations 
in the same study.  We also observed that force declined ~65% in cardiac myocyte 
preparation in response to 10 mM added Pi.  While data from skeletal muscle fiber 
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preparations report a wide range of force decline in response to added Pi (~30-55%), more 
recent data using myofibrils from fast-twitch skeletal muscle have reported greater effects of 
Pi (eg., 70% decline in force) with 10 mM Pi (146).  The exact reasons are unclear for the 
differences in Pi responsiveness between fibers and myofibrils preparations but may involve 
procedures used to reduce contaminating Pi as described by Pate et al. (109) and used in the 
myofibril experiments (147).  Also there is likely an inverse relationship between preparation 
diameter and force decline in response to added [Pi] because of greater accumulation of Pi 
from myofibrillar ATPases (and, thus, higher baseline [Pi]) in thicker preparations (70, 139).  
Regarding other contractile properties, added Pi has been reported to increase kPi (the rate 
constant of force decline after rapid increases in solution Pi) to a greater extent in cardiac 
myocyte preparations than in fast-twitch skeletal muscle fibers (4, 154).  Additionally, the 
increase in ktr with added [Pi] (from 0 mM to 10 mM) was upwards of three-fold in our 
skinned cardiac myocyte preparations versus a 50% increase in fast-twitch skinned skeletal 
muscle fibers (151).  Taken together, these results suggest contractile properties appear to be 
more sensitive to elevations in [Pi] in cardiac muscle than skeletal muscle at least over a 
range of 0-10 mM added Pi.  This may have implications in the response of these two striated 
types of myofibrils to metabolite (i.e., Pi) build up associated with ischemia.  For cardiac 
muscle, [Pi] is thought to rise to as high as 30 mM during ischemia (2), such a rise in [Pi] 
would likely result in a marked fall in force-generating cross-bridges but the faster rates of 
force development and loaded shortening would tend to compensate to possibly help sustain 
adequate stroke volume and cardiac output.   
 
A primary purpose of this study was to assess which step(s) in the cross-bridge cycle 
may be most important in determining myocyte shortening and power output at various 
loads.  In looking at a force-velocity curve (Figure 2.4), shortening velocity at low loads is 
thought to be limited by detachment of compressively strained cross-bridges, which appears 
to be limited by ADP release from actomyosin (131, 170) and/or by mechanical detachment 
of highly compressed cross-bridges (18).  Conversely, loaded shortening and power at high 
loads are thought to be determined by force-generating steps in the cross-bridge cycle, which 
are thought to be coupled to Pi release (53) and/or an isomerization that is in rapid 
equilibrium with Pi release from the actomyosin complex (94, 154).  The question then arises 
as to what load does the cross-bridge step(s) that limit power shift from force-generating 
transitions to detachment rates?   
Figure 2.4 
 
V
el
oc
ity
 (M
L/
se
c)
0.0
0.5
1.0
1.5
2.0
 tDetachmen 41
Relative F
0.0 0.2 0.4Force generating
transitionsorce
0.6 0.8 1.0
N
or
m
al
iz
ed
 P
ow
er
0.00
0.05
0.10
0.15
  42
Our experiments were designed to alter one of these processes (i.e., force-generating 
transitions) but not the other (i.e., detachment rates).  In this regard, elevations in Pi (from 0 
to ~15 mM) have been reported to speed the rates of force generation in skeletal (147, 151) 
and cardiac muscle preparations (4) but had minimal effects on unloaded shortening velocity 
in fast-twitch skeletal muscle fibers (17, 89, 158).  We also found no effect of 5 mM Pi on 
unloaded shortening velocity in skinned cardiac myocyte preparations (Figure 2.2).  Thus, we 
examined how added Pi affects power-load curves; if force-generating steps were the primary 
determinants over a large range of loads, then added Pi would increase power over much of 
the curve.  If, on the other hand, force-generating steps only determine power at high loads, 
accelerating these steps with added Pi should only increase power at high loads.  
Interestingly, loaded shortening and power output increased with 2.5 mM added Pi over all 
relative loads greater than ~10% isometric force (Figure 2.1).  In fact, both loaded shortening 
and power output continued to increase and reached a plateau at all loads greater than 10% 
isometric force when added [Pi] was increased to 5 mM.  These results suggest that force-
generating steps associated with Pi release are most important in limiting power output over 
most loads in cardiac myofibrils. 
 
Our results are also consistent with similar studies on skeletal muscle fiber 
preparations that sought insight into which chemomechanical transitions might determine 
power output at various loads.  For example, a study by Ford et al. (41) examined power 
output over a range of loads in rabbit skinned fast-twitch skeletal muscle fibers and 
discovered that osmotic compression of fibers resulted in reduced velocity and power at low 
loads but had little effect at intermediate and high loads.  Since osmotic compression slowed 
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unloaded shortening velocity this implies that cross-bridge detachment limits power output at 
low loads.  Consistent with this idea, lowering ATP concentrations or substituting ATP with 
CTP also slowed unloaded shortening velocity and decreased power output only at low loads 
in rat skinned slow-twitch skeletal muscle fibers (152).  A recent study also found that 
increased [Pi] sped loaded shortening in fast-twitch skeletal muscle fibers at loads greater 
than ~15% isometric force (38).  Taken together, these studies suggest that power output in 
striated myofibrils is rate-limited at low loads by the same chemomechanical transitions that 
limit unloaded shortening speeds whereas at intermediate and high loads it is limited by 
chemomechanical transitions that are associated with force-generation.   
 
Interestingly, the addition of Pi also increased the rates of force development but to a 
much greater extent than it did in peak normalized power.  The exact reasons for the different 
Pi dependencies of force development and power are unclear.  One possibility is that force 
development is limited by the cooperative activation of near-neighbor regulatory units on the 
thin filament by strongly binding cross-bridges (37, 39, 141) and addition of Pi increases the 
number of strongly binding non-force generating cross-bridges (A M ADP Pi).  This is 
consistent with the finding that Pi addition, like addition of strongly binding NEM modified 
cross-bridges (142), eliminated the slow phase of unloaded shortening following slack steps 
in skinned fast-twitch skeletal muscle fibers during submaximal Ca2+ activations (89).  
Loaded shortening, on the other hand, is not likely limited by the number of strongly bound 
non-force generating cross-bridges (A M ADP Pi) at least during maximal Ca2+ activations 
(86).  Rather, shortening velocity and power output (over most loads) appear to be 
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determined by Pi release steps in the cross-bridge cycle, which are modulated to a different 
extent than thin filament activation rates by addition of Pi. 
 
In summary, this study implies that myocyte power output is determined by Pi- 
sensitive force-generating transitions in the cross-bridge cycle as opposed to detachment of 
compressively strained cross-bridges.  However, even though Pi speeds loaded shortening at 
given relative loads, the increase in velocity does not appear to be great enough to 
compensate for the Pi-induced decrease in force; this yields an overall decrease in absolute 
power generating capacity, providing a myofibrillar mechanism for depressed myocardial 
work capacity and function during ischemia. 
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Chapter 3.  Β-MYOSIN HEAVY CHAIN MYOCYTES ARE MORE RESISTANT   
THAN Α-MYHC MYOCYTES TO CHANGES IN POWER OUTPUT 
INDUCED BY ISCHEMIC CONDITIONS. 
 
 
ABSTRACT 
 
During ischemia intracellular concentrations of inorganic phosphate (Pi) and 
hydrogen ions (H+) increase.  Also, changes in myosin heavy chain isoform (MyHC) from 
towards the β-MyHC isoform have been reported following ischemia and infarction 
associated with coronary artery disease.  The purpose of this study was to investigate the 
effects of myoplasmic changes of Pi and H+ on the loaded shortening velocity and power 
output of cardiac myocytes expressing either α- or β-MyHC.  Skinned myocytes were 
obtained from adult, male Sprague-Dawley rats (control or PTU treated to induce β-MyHC) 
and mounted between a force transducer and servo-motor system.  Myocytes were subjected 
to a series of isotonic force clamps to determine shortening velocity and power output during 
Ca2+ activations in each of the solutions: (i) pCa 4.5, pH 7.0, (ii) pCa 4.5, pH 7.0, 5 mM Pi, 
(iii) pCa 4.5, pH 6.6, and (iv) pCa 4.5, pH 6.6, 5 mM Pi.  Added Pi and lowered pH each 
caused isometric force to decline to the same degree in α-MyHC and β-MyHC myocytes, 
however, β-MyHC myocytes were more resistant to changes in absolute power output.  For 
example, peak absolute power output fell 53% in α-MyHC myocytes while power fell only 
38% in β-MyHC myocytes in response to elevated Pi and lowered pH (i.e., solution (iv)).  
The reduced effect on power output was the result of a greater speeding of loaded shortening 
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velocity induced by Pi in β-MyHC myocytes and an increase in loaded shortening velocity at 
pH 6.6 that occurred only in β-MyHC myocytes.  We conclude that the functional response 
to elevated Pi and lowered pH during ischemia is MyHC isoform dependent with β-MyHC 
myocytes being more resistant to declines in power output. 
 
INTRODUCTION 
The capability of the heart to pump blood is dependent upon its ability to contract against a 
load and thus generate power.  During times of reduced blood flow to the myocardium this 
pumping capability is compromised.  Multiple factors are involved in reducing contractile 
function of the myocardium during ischemia many of which are dependent upon the duration 
and severity of ischemia.  However, a principle cause for the fall in force production during 
early ischemia is thought to be the accumulation of metabolic byproducts specifically 
inorganic phosphate (Pi) and hydrogen ions (H+) (27, 30, 76, 104, 132).  Some of the effects 
of alterations in myoplasmic electrolyte composition occurring during myocardial ischemia 
on contractile function have been examined using skinned cardiac muscle.  Experiments 
utilizing skinned strips of cardiac trabeculae in the presence of 0-30mM  Pi demonstrated a 
progressive decrease in force production with increasing [Pi] (27, 69, 70, 103).  However not 
all effects appeared to be detrimental as [Pi] up to 10mM increased loading shortening at 
loads greater than 10% maximal isometric tension in single skinned cardiac myocytes (58).  
The increase in loaded shortening velocity at elevated Pi attenuated the fall in peak absolute 
power (the product of force and velocity), however the compensation was not enough to 
completely prevent a decline in absolute power production.  Increases in H+ (i.e. acidosis) 
that occur during ischemia also decrease cardiac myocyte function.  In contrast to Pi, H+ has 
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been reported to decrease unloaded and loaded shortening velocity in cardiac trabeculae 
preparations (120) in addition to decreasing isometric force production (32, 69, 90, 104).  
Studies examining increases of both Pi and H+ working in concert have primarily been 
limited to assessments of alterations in force production (69, 103, 150).  In cardiac muscle 
these two additively decrease isometric force (69, 103) while the effects upon loaded 
shortening and power output are unknown.  Thus, we tested the hypothesis that added Pi and 
H+ will act additively to decrease peak absolute power output in single skinned cardiac 
myocytes. 
 
When examining the effects of ischemia on the myocardium it is important to 
recognize that many factors including contractile protein isoform expression may contribute 
to the functional response.  Studies using skinned skeletal fibers have reported lesser 
depressant effect of Pi (103) or H+ (91) on force in slow-twitch fibers than fast-twitch fibers.  
This may be especially significant in mammalian hearts as myosin heavy chain (MyHC) 
isoform changes toward β-MyHC isoform (which is the same isoform as in slow-twitch 
fibers) following prolonged ischemia, infarction, and during heart failure (119, 167, 169).  
The potential differential effects of ischemic metabolites on power output of cardiac 
myocytes have not been previously examined even though a switch towards a more resistant 
isoform would appear to be advantageous teleologically in situations of ischemic heart 
disease.  Thus, we examined the effects of increased metabolite concentration on force, 
loaded shortening velocity and power output of single skinned cardiac myocytes primarily 
expressing either α- or β-MyHC.  Utilizing Triton-skinned cardiac myocytes from control 
and PTU-treated rats (to induce β-MyHC expression) force-velocity relationships were 
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determined in the presence of Pi (5mM) or H+ (pH 6.6) alone and together to determine the 
effect of simulated ischemic conditions on myocyte function.  The results show that Pi and 
H+ act additively to depress force in both α- and β-MyHC myocytes.  Additionally, 5mM Pi 
increased loaded shortening velocity in both α- and β-MyHC myocytes.  Lowered pH had no 
effect on loaded shortening in α-MyHC myocytes but increased loaded shortening in β-
MyHC myocytes.  From these results it was concluded that α-MyHC and β-MyHC myocytes 
are equally sensitive to depression of force by Pi and H+ but β-MyHC myocytes are more 
tolerant to changes in metabolite concentrations as indexed by power generating capacity. 
   
METHODS 
 
 
Cardiac myocyte preparation 
Sprague-Dawley rats were obtained from Harlan (Madison, WI) and maintained 
according to guidelines set by the Animal Care and Use Committee of the University of 
Missouri.  Single skinned cardiac myocytes were obtained from rats treated for ~3 weeks 
with 5-n-propyl-2-thiouracil (PTU; 0.6g/L in drinking water) or age-matched controls by 
mechanical disruption of hearts as described previously (85).  PTU treatment has been 
successfully employed to shift MyHC expression from primarily α-MyHC to the β-MyHC 
isoform (51).  Rats were anaesthetized by inhalation of isoflurane (0.05 mg) for 2-4 minutes 
in an airtight one-liter container and their hearts were excised and rapidly placed in ice cold 
relaxing solution.  The ventricles were dissected away from the atria, cut into 2-3 mm pieces 
and further disrupted for 5-10 seconds in a Waring blender all in the presence of ice-cold 
relaxing solution.  The resulting suspension of cells was centrifuged for 65 sec at 165 x g, 
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after which the supernatant was discarded.  The myocytes were skinned by suspending the 
pellet of cells for 3 min in 0.5 % ultrapure Triton X-100 (Pierce Chemical Co.) in relaxing 
solution.  The skinned cells were washed twice with cold relaxing solution, suspended in 10-
15 ml of relaxing solution and kept on ice during the day of the experiment.  Myocytes were 
used within 12 hours of isolation. 
 
Solutions 
Relaxing solution in which the ventricles were disrupted, skinned, and resuspended 
contained (in mmol/L): EGTA 2, MgCl2 5, ATP 4, imidazole 10, and KCl 100 at pH 7.0.  
Compositions of relaxing and activating solutions used in mechanical measurements were as 
follows (mmol/L):  EGTA 7, free Mg2+ 1, imidazole 20, MgATP 4, creatine phosphate 14.5, 
Ca2+ concentrations of 10-9 M (relaxing solution) and 10-4.5 M (maximal activating solution), 
and sufficient KCl to adjust ionic strength to 180 mM.  Starting from a very acidic pH (~4) 
final solution pH was given by KOH addition to either 6.6 or 7.0.  Activating solutions 
containing Pi were identical to those described above except for inclusion of 5 mM of 
potassium phosphate (KH2PO4) before adjustment to ionic strength of 180 mM.  The final 
concentrations of each metal, ligand and metal-ligand complex at 13°C were determined with 
a computer program (31).  Immediately preceding activations, muscle preparations were 
immersed for 60 s in a solution of reduced Ca2+-EGTA buffering capacity, identical to 
normal relaxing solution except that EGTA is reduced to 0.5 mM.  This protocol resulted in 
more rapid steady state force development and helped preserve the striation pattern during 
activation.   
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Experimental Apparatus, mechanical measurements and data analysis 
  See experimental apparatus, mechanical measurements, and data analysis section in 
Chapter 2. 
 
SDS-PAGE and MyHC quantification.  
After mechanical measurements, MHC isoform expression was determined for each 
myocyte preparation as previously described (51).  Briefly, myocytes were removed from the 
experimental apparatus, suspended in 8 µl of SDS sample buffer, and stored at -80°C for 
subsequent SDS-PAGE analysis.  The gels for SDS-PAGE were prepared with 3.5% 
acrylamide in the stacking gel and 12% acrylamide in the resolving gel.  Samples were 
separated by SDS-PAGE at constant voltage (250 V) for 8.0 h.  Gels were initially fixed in an 
acid-alcohol solution, followed by glutaraldehyde fixing.  MyHC isoforms were visualized by 
ultrasensitive silver staining, and gels were subsequently dried between mylar sheets.  The 
relative expression of each MyHC isoform was determined using QuantiScan (Biosoft) 
software and an Epson scanner to measure the relative intensity and area of each MyHC 
band. 
 
Statistics 
 One–way repeated measures ANOVA were used to determine significant effects on 
force, absolute and normalized power output, and ktr from varied Pi and H+ solutions.  The 
Student-Newman-Keuls test was used post hoc to assess the differences among means.  
Student t-tests were used to assess differences in metabolite effect between myocytes 
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expressing α-MyHC or β-MyHC.  P < 0.05 was chosen as indicating significance.  Values 
are expressed as means ± SD unless otherwise indicated. 
 
RESULTS 
 
Myocyte characteristics and PTU induced changes in MyHC expression 
PTU treatment of rats has been employed frequently to induce MyHC isoform 
switching with minimal changes in other myofilament protein expression or overall myocyte 
morphology (51, 59, 123).  Addition of PTU to the drinking water decreased the expression 
of α-MyHC protein while increasing β-MyHC isoform expression.  MyHC content of 
myocytes used in mechanical experiments was determined by SDS-PAGE separation; an 
example of MyHC separation gels is shown in figure 1B.  Myocytes from non-PTU treated 
animals expressed 91 ± 4% α-MyHC protein, while those from age matched animals 
following ~3 weeks of PTU treatment yielded myocytes with 11 ± 5% α-MyHC.  Similar to a 
previous study (51), non-treated and PTU-treated myocytes were the same in length (α-
MyHC 148 ± 39 µm; β-MyHC 161 ± 43 µm) and width (α-MyHC 24 ± 9 µm; β-MyHC 22 ± 
4 µm).  Resting sarcomere length (SL) of the preparations when set to yield passive forces 
near zero was 2.33 ± 0.07 µm and 2.25 ± 0.04 µm in α-MyHC and β-MyHC myocytes, 
respectively, and was not altered by maximal Ca2+ activation (i.e., pCa 4.5) (α-MyHC 2.32 ± 
0.08 µm; β-MyHC 2.26 ± 0.05 µm), which is indicative of low compliance at the points of 
myocyte attachment. 
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Effects of ischemic conditions on mechanical properties of cardiac myocytes 
Previous experiments on skinned cardiac trabeculae (69, 70, 103) and myocytes (58, 
150) have shown increased [Pi] and/or [H+] decreased maximal Ca2+ activated force.  
Comparable force and declines in force were observed in this study during addition of Pi and 
H+ alone and together, with α-MyHC and β-MyHC myocytes having equal decreases.  Force 
and force per cross-sectional area in rat skinned cardiac myocytes are summarized in Tables 
3.1 (α-MyHC myocytes) and 3.2 (β-MyHC myocytes).  In α-MyHC myocytes maximal Ca2+ 
activated force per cross-sectional area was 62%, 62% and 40% of control force in solutions 
containing 5mM Pi (solution ii), at pH 6.6 (solution iii), and 5mM Pi at pH 6.6 (solution iv), 
respectively.  β-MyHC myocytes produced 58%, 59% and 35% of maximal Ca2+ activated 
tension at pH 7.0, 0mM Pi with (solution ii) 5mM Pi, (solution iii) pH 6.6, and (solution iv) 
5mM Pi at pH 6.6, respectively.  These results indicate that Pi- and H+-induced decreases in 
force are independent of mammalian MyHC isoform. 
 
Force-velocity and power-load relationship characteristics are given in Tables 3.1 and 
3.2, for α-MyHC and β-MyHC myocytes, respectively.  Figure 3.1 displays a representative 
absolute force-velocity and power-load relationship from a non-PTU treated myocyte (i.e., α-
MyHC myocyte) under all four of the experimental conditions.  Addition of Pi or lowering 
the pH of the activator solution resulted in a leftward shift of the absolute force-velocity 
relationship (Figure 3.1) because of lower isometric force.  Also, even though addition of 
5mM Pi and the lowering of the pH to 6.6 reduced force to the same extent, there was 
significantly greater peak absolute power output with Pi than with lowered pH (bottom of 
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       Figure 3.1 
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Figure 3.1  Effect of experimental conditions on absolute force-velocity and power-load 
relationships in an α-MyHC myocyte.   
 
A.  Photomicrographs of a single cardiac myocyte during relaxation (pCa 9.0) and at 
maximal Ca2+ activation (pCa 4.5).  B.  Representative silver stained MyHC gel following 
SDS-PAGE separation.  Lanes contain MyHC bands from single myocytes from rats 
following PTU treatment for 10 days (lane 1), 0 days (lane 2) and 21 days (lane 3).  The 
MyHC pattern in lane 3 is from the myocyte shown in the photomicrographs and whose 
experimental data is shown in (C) and (D).  C.  Representative length traces during force 
clamps of a rat skinned cardiac myocyte preparation during maximal Ca2+ activations in the 
presence of 0 and 5 mM added Pi at pH 7.0 and 6.6.  D.  Absolute force-velocity and power-
load relationships of the myocyte in lane 2 above (B) expressing ~95% α-MyHC with each 
experimental condition.  Isometric force decreased equally with addition of 5 mM Pi or 
decreasing the pH to 6.6 and fell further with 5 mM Pi at pH 6.6 all of which shifted their 
respective force-velocity relationships to the left.  Leftward shifting of the force-velocity 
relationship resulted in less absolute power output at a given force.  However, the decline in 
power was less than the fall in force in the presence of 5 mM Pi at either pH 7.0 or 6.6.
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 Figure 3.1). The absolute power output of α-MyHC myocyte preparations fell ~20% with 
5mM Pi, ~40% at pH 6.6, and ~50% with 5mM Pi at pH 6.6, all significantly less than power 
output without additional Pi at pH 7.0.  However, the fall in power with additional Pi at either 
pH 7.0 or 6.6 was less than was expected from the fall in force whereas the fall in power at 
pH 6.6 without added Pi was equivalent to the fall in force.  The reason for less decline in 
power output than force with Pi (at pH 7.0 or 6.6) in α-MyHC myocytes is more easily seen 
with force-velocity relationships normalized to isometric force.  Normalized α-MyHC 
myocyte force-velocity relationships (Figure 3.2) reveal an increase in the velocity of 
shortening occurring with addition of Pi while increased H+ alone had no effect on loaded 
shortening velocity.  The increase in loaded shortening velocity increased power at all loads 
greater than ~10% isometric force in all α-MyHC myocytes, with normalized peak power 
output being ~30% greater with 5mM Pi, unchanged at pH 6.6, and 16% greater with 5mM Pi 
at pH 6.6.  Interestingly, the Pi-induced increase in loaded shortening velocity was attenuated 
in combination with elevated H+. 
 
In contrast to α-MyHC, β-MyHC myocyte absolute power generating capacity was 
not diminished by either 5mM Pi or pH 6.6, however, power did fall when applied in 
combination (Table 3.2).  The normalized force-velocity relationships of β-MyHC myocytes 
(Figure 3.3) reveal increases in the velocity of shortening occurring with addition of Pi and 
H+ alone and in combination.  Moreover, these increases were much greater than those 
observed in α-MyHC myocytes with 5mM Pi producing a 73% increase, pH 6.6 a 43% 
increase, and 5mM Pi at pH 6.6 a 88% increase in peak normalized power output.  These 
increases in loaded shortening velocity provided the basis for the preserved absolute power 
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Figure 3.2.  Normalized force-velocity and power-load relationships from α-MyHC 
myocytes.   
Force-velocity and normalized power-load curves shifted upward in response to added Pi 
while there was no effect with lower pH in α-MyHC myocytes (n = 9).  Upward shifts 
indicating increases in loaded shortening velocity occurred with Pi and helped to maintain 
power generating capacity.  Points are mean ± S.E. of the combination of all data points at 
similar forces. 
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generating capacity of β-MyHC myocytes.  Also of interest, the Pi-induced increase in loaded 
shortening velocity was augmented by added H+ in β-MyHC myocytes, which was opposite 
that seen in α-MyHC myocytes.  Larger increases in loaded shortening velocity with 
metabolites in β-MyHC myocytes than α-MyHC myocytes resulted in similar power 
generating capacity.  Normally, as with control conditions, α-MyHC myocytes generate more 
power than β-MyHC myocytes, however addition of Pi or H+ removed this difference 
resulting in similar power production. 
 
Finally, the rate constant of force redevelopment (ktr) was assessed in α- and β-MyHC 
myocytes with each experimental condition.  Pi addition increased ktr in α-MyHC myocytes 
at both pH 7.0 and 6.6, while lowered pH alone did not affect force redevelopment rates 
(Table 3.1).  Similar alterations in ktr with Pi and H+ have previously been reported for α-
MyHC myocytes (4, 58).  On the other hand, β-MyHC myocyte force redevelopment rates 
were not statistically significantly different with Pi or H+ addition (Table 3.2) however there 
was a trend for Pi addition at pH 7.0 to increase ktr (p = 0.07).   
 
DISCUSSION 
 
 
This study directly examined the effect of increases in Pi and H+ on cardiac myocyte 
force production, loaded shortening velocity, power output and rates of force development.   
Moreover, experiments utilized myocytes expressing predominantly either α-MyHC or β-
MyHC to ascertain if there is a cardiac MyHC dependent response to ischemic metabolite 
                                     Figure 3.3 
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Figure 3.3.  Normalized force-velocity and power-load relationships from β-MyHC 
myocytes. 
Force-velocity and normalized power-load curves shifted upward in response to added Pi 
while there was no effect with lower pH in β-MyHC myocytes (n = 8).  Upward shifts 
indicating increases in loaded shortening velocity occurred with Pi and H+ helped to maintain 
power generating capacity.  Points are mean ± S.E. of the combination of all data points at 
similar forces. 
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 concentration.  The main findings of this study were as follows:  1) maximal Ca2+ activated 
tension decreased comparably in α-MyHC and β-MyHC myocytes with Pi and lowered pH 
both alone and together; 2) Pi addition increased loaded shortening velocity in both α-MyHC 
and β-MyHC myocytes; 3) lowered pH had no effect on velocity of shortening in α-MyHC 
myocytes but increased loaded shortening velocity in β-MyHC myocytes; and 4) power 
generating capacity of α-MyHC myocytes fell to a greater extent with Pi and H+ than β-
MyHC myocytes resulting in similar power output between α-MyHC and β-MyHC myocytes 
during Ca2+ activations in the presence of Pi and lowered pH separately and together.  From 
this it can be concluded that MyHC does not affect the force response to metabolite 
accumulation in cardiac myocytes, however MyHC is a determinant of the effect on loaded 
shortening and power output.  The differential effects of these conditions on shortening 
velocity between α- and β-MyHC myocytes may represent a mechanism whereby the heart 
compensates to maintain function during pathological conditions (repeated ischemia or 
congestive heart failure) by expressing the more tolerant MyHC isoform (β-MyHC). 
 
MyHC as a determinant of force-velocity and power-load properties of cardiac 
myocytes during simulated ischemic conditions. 
 
 The inhibitory effects of ischemic metabolites on force production in muscle have 
been investigated extensively in skinned skeletal and cardiac preparations.  Some of these 
studies have provided the possibility of an inverse relationship between preparation diameter 
and force decline (70, 139) which is thought to exist because of lower Pi accumulation from  
myofibrillar ATPases in thinner preparations during Ca2+ activation.  Importantly though, 
this would indicate that the scale of ATPase activity may also be a determinant of force 
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Figure 3.4.  Comparative plots of force and power production between α- and β-MyHC 
myocytes. 
A.  Effect of Pi and decreased pH on myocyte force production in α-MyHC and β-MyHC 
myocytes.  Values are scaled to the value at pH 7.0 with no added Pi.  Force declined 
similarly between myocyte populations expressing either α-MyHC or β-MyHC.  B.  Absolute 
power production between α-MyHC and β-MyHC myocytes.  α-MyHC myocyte power 
production while greater than β-MyHC myocyte power with no added Pi at pH 7.0, fell to 
comparable levels as β-MyHC myocytes with Pi or H+ alone or in combination. 
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 sensitivity to metabolites, meaning a more active ATPase will result in greater accumulation 
(at a given diameter).  This is in agreement with some recent data showing more 
responsiveness in fast-twitch compared to slow-twitch skeletal muscle fibers (94, 103, 146).  
However, this idea remains controversial as studies have also reported greater metabolite 
sensitivity in slow-twitch fibers (23) or no difference (113) between fiber type force 
response.  The disparity of these results may lie in experimental solutions or conditions, such 
as temperature as force sensitivity to metabolites is temperature dependent (23).  
Nevertheless the potential difference between skeletal fiber-type sensitivity to metabolites 
suggests the potential for a MyHC-dependence of force response to Pi and H+ in cardiac 
muscle.  In vertebrates, two MyHC isoforms are expressed in the myocardium, α-MyHC and 
β-MyHC, with considerable homology containing 93% identical amino acids (88), but are 
functionally distinct.  For example, α-MyHC exhibits two to three times the actin-activated 
ATPase activity (82) and generates ~3 times more power than β-MyHC (51).  However, 
analysis of differential force response to Pi and H+ with cardiac MyHC content has not been 
addressed to our knowledge.  Comparison of results from some studies may offer potential 
support for a MyHC dependence of force response in cardiac muscle.  For example, van der 
Velden et al. (150) reported a ~35% decline in force per decade of Pi in human donor and 
heart failure ventricular myocytes, both of which likely express β-MyHC primarily, while 
others have reported larger (45-65%) declines per decade in rat cardiac preparations 
expressing primarily α-MyHC (27, 58, 69) .  Yet direct comparison of these results may be 
errant as they were collected under different experimental conditions with preparations of 
varying size, which as discussed above, may be an important variable in the response to 
metabolite accumulation.  Though, in regards to differential Pi effect due to size, our previous 
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work (58) and the van der Velden study (150) both utilized single ventricular cardiac 
myocytes and yet produced very different force response to 10 mM Pi, 35% and 65% 
declines in α-MyHC and β-MyHC myocytes, respectively.  The reason for this difference is 
unclear at this time but may be the result of differential myofibrillar protein phosphorylation 
status as proposed (150), solutions used, myocyte preparation or myofilament protein 
expression.  As for the response of cardiac myocytes to acidosis, Solaro et al. showed that 
neonatal myocardium is less sensitive to acidosis than adult myocardium (133).  However, 
the authors concluded the change in sensitivity of force production observed was the result of 
a shift in troponin I isoform from the slow skeletal isoform in neonates to the cardiac isoform 
in adults, although heavy chain expression was not completely characterized.  In this study an 
equivalent drop in force was observed between α-MyHC and β-MyHC myocytes with Ca2+-
activating solutions at lower pH or containing Pi implying cardiac MyHC independence to 
these conditions (Figure 3.4).  This supports that ATPase rate, and consequent metabolite 
production, is not a major determinant of metabolite sensitivity of force at least in single 
myocyte preparations where the diameter is small and equivalent.  Finally, the combined 
effect of Pi and H+ on force production was comparable in α-MyHC and β-MyHC myocytes 
and while additive there was no synergistic effect (whole greater than the sum of the parts) in 
combination, in agreement with previous studies in cardiac muscle (69, 103, 150). 
 
 In this study Pi and H+ affected loaded shortening differentially in myocytes 
expressing α-MyHC and β-MyHC.  α-MyHC myocytes displayed (1) faster loaded 
shortening velocity with Pi, (2) no effect with H+ itself, and (3) an attenuated Pi effect on 
velocity when applied in combination with H+.  Alternatively, β-MyHC myocytes (1) 
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exhibited greater increases in loaded shortening than α-MyHC myocytes with Pi, (2) were 
also faster with H+ and (3) displayed faster loaded shortening when applied in combination 
than either alone (but not to a statistically significant level).  It was this greater effect of Pi 
and H+ on β-MyHC myocyte loaded shortening velocity that maintained the power 
generating capacity of the myocyte even with the fall in force.  Maintenance of power 
generating capacity may be important functionally during the ejection phase of the cardiac 
cycle when the ventricle is shortening against a load and generating power.  If the velocity of 
shortening is sustained at a given load, then the extent to which the myocytes shorten and 
consequently the ventricles contract during a heartbeat will remain similar, thereby 
alleviating any fall in ejection volume during ischemia.  Under similar Ca2+ activated 
conditions α-MyHC myocytes can generate more power and thus shorten faster at a given 
load than β-MyHC myocytes.  However, the difference in power capacity between α-MyHC 
and β-MyHC myocytes is diminished with increased Pi and/or H+ to the point where 
essentially there is no difference in power generation between α-MyHC and β-MyHC 
myocytes with either Pi or H+ alone or in combination (Figure 3.4).  Furthermore, increases 
in metabolites to concentrations greater than employed in this study may actually result in β-
MyHC myocytes maintaining their functional capacity while α-MyHC myocytes continue to 
decline.  We were unable to test this idea as force production falls to levels that become 
experimentally limiting in our myocyte preparation. 
 
 Our earlier work (58) demonstrated an increase in loaded shortening velocity of 
cardiac myocytes with increased [Pi]; here we extend that work by reporting the effects of Pi 
addition and lowered pH individually and in combination, which commonly occurs during 
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ischemia in vivo, in α- and β-MyHC myocytes.  The Pi-induced increase in loaded shortening 
velocity occurred in both α- and β-MyHC myocytes resulting in greater peak power output 
when normalized for the fall in isometric force.  Pi addition is thought to decrease force 
production by shifting populations of cross-bridges from a force-generating state in which the 
actomyosin complex has ADP alone bound (AM-ADP) to a weakly or strongly bound lower-
force generating state in which both ADP and Pi are bound (AM-ADP-Pi) (53).  Pi addition 
also speeds the kinetics of transition through the force-generating steps leading to Pi release 
(4).  We previously concluded that loaded shortening and power output at intermediate and 
high loads are determined by force-generating transitions coupled to Pi release and/or an 
isomerization that is in rapid equilibrium with Pi release from the actomyosin complex (58).  
On the other hand, H+ alone had no effect in α-MyHC myocytes, but it attenuated the Pi-
induced speeding of loaded shortening velocity when used in combination with Pi.  Our result 
of lowered pH having no effect on loaded shortening velocity contrasts a previous report 
where velocity decreased (120).  The reason for the discrepancy between results is not clear 
but it may be due to preparation size as the trabeculae preparation used in that study had 
greater than 20 times cross-sectional area of our myocyte preparation, or differences in 
solution composition.  Attenuation of the Pi effect by lower pH that occurred may be the 
result of H+ reducing the pool of strongly-bound cross-bridges by driving them to a weakly 
bound state, which has been postulated previously (69).  Alternatively, it may be that H+ 
directly slows Pi release from the ATP binding cleft, which may also slow loaded velocity.  
In contrast to α-MyHC myocytes, lowered pH did not attenuate the Pi-induced increase in 
loaded shortening velocity in β-MyHC myocytes; in fact loaded shortening was augmented 
toward faster velocities at the same load but this difference did not reach significance.  
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Augmentation of loaded shortening may be the consequence of H+ speeding Pi release in β-
MyHC myocytes.  Nevertheless there is a MyHC dependent difference in response to Pi at a 
lower pH in cardiac myocytes and the sub-molecular mechanisms are unknown. 
 
 Rate of force development increases with Pi in both cardiac myocytes (4, 58) and 
skeletal muscle fibers (92) while no change occurs with pH in skeletal muscle fibers during 
maximal Ca2+ activation (91).  Importantly, it is the rate of force development that likely 
determines how quickly the ventricles complete isovolumic contraction (phase 2 of the 
cardiac cycle) allowing the remaining time of systole for ejection (phase 3).  α-MyHC 
myocytes develop force 2-3 times more quickly than do β-MyHC at maximal Ca2+ activation 
(here and (40)), which likely allows for the ejection phase to commence earlier and last 
longer in working ventricles.  In addition, α-MyHC myocytes appear to benefit from this Pi-
induced increase in force development to a greater extent than β-MyHC myocytes.  This may 
ultimately mean that even though α-MyHC myocyte loaded shortening is more greatly 
attenuated by ischemic metabolites global ventricular function may be maintained as faster 
isovolumic allows for more ejection time. 
 
Possible implications for impaired function in heart disease 
 Myocardial tissue exposed to ischemic conditions has been shown to have greater 
relative expression of β-MyHC in adult rat cardiac myocytes than control tissues (167, 169).  
Expression of β-MyHC in myocytes reduces their power generating capacity (51) but in 
doing so these myocytes appear to become both more economical (123) and more resistant to 
the effects of ischemic metabolites (this study).  Thus, β-MyHC appears to provide more 
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resistance to falls in energy charge as it produces force at a much smaller energy cost (123) 
and faster loaded shortening velocity with increased metabolites.  In agreement with this, 
post-ischemic function was greater in hearts expressing some (~25%) β-MyHC as compared 
to control rat hearts (10).  Theoretically, myocardium exposed to repeated bouts of ischemia 
may attempt to offset reductions in myocyte function occurring as a result of lowered [ATP] 
or free energy of ATP hydrolysis by expressing the more economical isoform of MyHC thus 
conserving ATP as less is consumed at the myofilaments.  Decreased actomyosin activity and 
ATP conservation may also be important as a decrease in [ATP] leading to a decrease in 
ATPase activity, specifically ones associated with Ca2+-extrusion (SR and sarcolemmal Ca2+ 
ATPases), is thought to be causal for apoptosis and more chronic dysfunction (as reviewed 
by (5, 12)).  In addition to β-MyHC expression conceivably being protective to myocardium 
that is frequently made ischemic, increased β-MyHC expression also commonly occurs 
during the progression to heart failure experimentally and clinically (119, 167, 169).  Thus, 
β-MyHC expression also appears to be important in the transition to a compensated heart in 
response to pathophysiological stimuli perhaps by preserving myocardial function during 
energetic challenge.   
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Chapter 4.  PORCINE CARDIAC MYOCYTE POWER OUTPUT IS INCREASED 
FOLLOWING CHRONIC EXERCISE TRAINING 
 
 
ABSTRACT 
 
Chronic exercise training increases the functional capacity of the heart perhaps by 
increased myocyte contractile function, as has been observed in rodent exercise models.  We 
examined whether cardiac myocyte function is enhanced following chronic exercise training 
in Yucatan miniature swine, whose heart characteristics are similar to humans.  Animals 
were designated as either sedentary (SED), cage confined, or exercise trained (EX), 
underwent 16 to 20 weeks of progressive treadmill training.  Exercise training efficacy was 
shown with significantly increased heart weight to body weight ratios, skeletal muscle citrate 
synthase activity, and exercise tolerance.  Force-velocity properties were measured by 
attaching skinned cardiac myocytes between a force transducer and position motor and 
shortening velocities were measured over a range of loads during maximal Ca2+ activation.  
Myocytes from EX pigs (n = 9) had comparable force production but a ~30% increase in 
peak power output compared to SED myocytes (n = 8).  Interestingly, EX myofibrillar 
samples also had higher baseline PKA-induced phosphorylation levels of myosin binding 
protein-C (MyBP-C) and cardiac troponin I (cTnI), which may contribute to the increase in 
power.  Overall, these results suggest that enhanced power generating capacity of porcine 
cardiac myofibrils contributes to improved cardiac function following chronic exercise 
training.   
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INTRODUCTION 
 
Chronic exercise is known to improve cardiac function as indexed by increases in 
maximal levels of cardiac output (CO) and stroke volume (SV) (125).  While increased CO is 
an ultimate goal of exercise training, enhanced SV is a primary adaptation given the fact 
lower heart rates (HR) occur at a given workload following chronic exercise training (29).  
The increase in stroke volume is thought to be due, in part, to training-induced alterations of 
the intrinsic contractile function of the myocardium (36, 66, 95).  Alterations of contractile 
function following exercise are accompanied by increases in force production due to myocyte 
hypertrophy (101), increased Ca2+ sensitivity of force (26), and possibly increased shortening 
velocities (163).  There also have been a few studies that focused on the effects of exercise 
training on the entire force-velocity relationship as it is velocity of shortening under a load 
that is most applicable to in vivo ventricular function.  Two studies utilizing a rat model of 
chronic exercise training reported increased loaded shortening velocities in myocardial 
preparations from trained animals (25, 95).  However, alterations in loaded shortening have 
not been investigated in other animal models, specifically larger animal models such as swine 
that may more closely mimic human physiology. 
 
The purpose of this study was to evaluate cardiomyocytes from a pig model of 
exercise training for mechanical changes intrinsic to the myofilaments.  The use of a porcine 
model of exercise training to investigate physiological changes that occur in large mammals 
may be applicable to humans as pigs and humans have similar heart morphology and 
adaptive responses to chronic exercise with respect to maximal oxygen consumption 
(VO2max), SV, HR and skeletal muscle oxidation capacity (for review see (87)).  This model 
  71
previously has been shown to produce increased exercise tolerance, moderate cardiac 
hypertrophy, increased coronary blood flow capacity, increased oxidative capacity of skeletal 
muscle and lower heart rates during exercise at submaximal intensities (77).  These changes 
occurred without any apparent alterations in myofibrillar ATPase, Ca2+ regulatory systems, 
or the metabolic system (77).  Since CO was sustained with lower HR at submaximal 
workloads, this implies increased SV.  Increased SV could be the result of a number of things 
including less aortic resistance, greater ventricular volume, and/or increased myocardial 
contractility.  The main objective of this study was to determine if cardiac myofibrillar 
contractility differs between sedentary (SED) and exercise trained (EX) pig myocytes to 
account, at least in part, for the increased SV.  Contractile function was assessed in 
permeabolized cardiac myocyte preparations by measuring isometric force, loaded shortening 
velocity, power output and rate of force development during maximal Ca2+ activation.  
Another objective was to determine if alterations in cardiac myofibrillar proteins may 
account for any observed functional differences.  Specifically, we examined relative myosin 
heavy chain (MyHC) isoform contents, relative cardiac troponin T (cTnT) isoform contents, 
and PKA-induced baseline phosphorylation of the myofibrillar proteins myosin binding 
protein-C (MyBP-C) and cardiac troponin I (TnI). 
 
METHODS 
Animal Model 
Adult male miniature swine weighing 25-40 kg were obtained from the breeder 
(Charles River) and familiarized with treadmill exercise over a 1- to 2-wk period of time. 
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Treadmill performance tests were administered to each animal to evaluate exercise tolerance 
as previously described (77).  Pigs were randomly assigned to SED or EX groups, with the 
EX group completing the 16- to 20-wk endurance training program described previously (77, 
78).  Pigs assigned to the SED group were restricted to their enclosures (2 x 4 m) and did not 
exercise.  Treadmill performance tests were again completed at the end of 18-20 weeks to 
determine the effectiveness of the training protocol on exercise duration.  The overall 
efficacy of the training program was determined by comparing the exercise tolerance (as 
reflected in the treadmill performance test), heart weight-to-body weight ratios, and skeletal 
muscle oxidative capacity of trained and control groups.  At the time of sacrifice, samples 
were taken from the middle of deltoid muscles, frozen and stored at -70°C for citrate synthase 
analysis.  Citrate synthase activity was measured from whole muscle homogenate using the 
spectrophotometric method of Srere (137).  Animal care and use procedures complied with 
the Guide for the Care and Use of Laboratory Animals issued by the National Institutes of 
Health and were approved by the University of Missouri Animal Care and Use Committee. 
Isolation of cardiac myocytes   
The heart was excised from the experimental animal following administration of a 
pre-anesthetic mixture of ketamine (35 mg/kg) and xylazine (2.25mg/kg) and the general 
anesthesia thiopental (25 mg/kg).  A piece (3 x 3 cm) of left ventricular free wall near the left 
anterior descending coronary artery was removed with one half quick frozen in liquid 
nitrogen for biochemical analyses and the other half placed in ice cold relaxing solution for 
myocyte experiments.  The piece in relaxing solution was cut into smaller pieces (2-3mm) 
and homogenized with a hand blender.  The resultant slurry was transferred via pipette into 
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15 mL tubes that were centrifuged 75 sec at 165 x g after which the supernatant was 
discarded.  The cells were suspended for 3 min in 0.5% ultra pure Triton X-100 (Pierce 
Chemical Co.) in relaxing solution.  The skinned cells were washed twice with cold relaxing 
solution, centrifuged, and suspended in 10-15 ml of relaxing solution and kept on ice during 
the day of the experiment.  Myocytes were used within 12 hours of isolation. 
Solutions 
Relaxing solution in which the ventricles were disrupted, skinned, and resuspended 
contained (in mmol/L):  EGTA 2, MgCl2 5, ATP 4, imidazole 10, and KCl 100 at pH 7.0.  
Compositions of relaxing and activating solutions used in mechanical measurements were as 
follows (mmol/L):  EGTA 7, free Mg2+ 1, imidazole 20, MgATP 4, creatine phosphate 14.5, 
pH 7.0, Ca2+ concentrations of 10-9 M (relaxing solution) and 10-4.5 M (maximal activating 
solution), and sufficient KCl to adjust ionic strength to 180 mM.  The final concentrations of 
each metal, ligand and metal-ligand complex at 12°C were determined with the computer 
program of Fabiato (31).  Immediately preceding activations, muscle preparations were 
immersed for 60 s in a solution of reduced Ca2+-EGTA buffering capacity, identical to 
normal relaxing solution except that EGTA is reduced to 0.5 mM.  This protocol resulted in 
more rapid steady state force development and helped preserve the striation pattern during 
activation.   
 
Experimental Apparatus, Mechanical measurements, and Data analysis. 
 See Chapter 2.  
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SDS-PAGE, Western blot and Autoradiography.  
After mechanical measurements, MHC isoform expression was determined for each 
myocyte preparation. The single myocyte was removed from the experimental apparatus, 
suspended in 8 µl of SDS sample buffer, and stored at -80°C for subsequent SDS-PAGE 
analysis. The gel electrophoresis procedure was similar to one previously described (93).  
The gels for SDS-PAGE were prepared with 3.5% acrylamide in the stacking gel and 12% 
acrylamide in the resolving gel. Samples were separated by SDS-PAGE at constant voltage 
(250 V) for 6.5 h. Gels were initially fixed in an acid-alcohol solution, followed by 
glutaraldehyde fixing. MHC isoforms were visualized by ultrasensitive silver staining, and 
gels were subsequently dried between mylar sheets. 
 
Western blot analyses were completed as previously described (74).  Briefly, serial 
dilutions (2, 1, 0.5 µg) of left ventricular homogenates were prepared in SDS sample buffer 
and separated by SDS-PAGE as described above except the runtime was reduced to 3 hours.  
Gels were placed on nitrocellulose membrane and transferred from the gels to nitrocellulose 
using a semidry blot apparatus for 45-60 min at constant current (100 mA).  The 
nitrocellulose membranes then were placed in a blocking buffer (3% BSA in Tris-buffered 
saline plus Tween 20 (TTBS)) and rocked overnight at 4°C.  The blocking buffer was 
removed, and membranes washed in TTBS.  The primary cTnT antibody (Advanced 
Immunochemical) (cTnT 1:2,000 in 0.6% BSA in TTBS) was allowed to react with 
membranes for 1 h followed by washing in TTBS.  Secondary antibody (S-adenosyl-L-
methionine-IgG 1:2,500 in 0.3% BSA in TTBS) reacted for 1 h followed by three washes 
using TTBS.  On completion of the final wash, membranes were coated 1 min with enhanced 
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chemiluminescent substrate (Amersham) that reacts with the secondary antibody.  
Membranes were placed between two pieces of clear acetate and exposed to photography 
film for ~1 min, followed by film development to detect relative amounts of cTnT protein 
isoforms. Relative amounts of each isoform were determined by measuring the areas under 
the peaks using QuantiScan (Biosoft) software and an Epson scanner. 
 
To determine the PKA-induced phosphorylation status of the myofibrillar substrates, 
myofibrillar samples were incubated with the catalytic subunit of PKA in the presence of 
radiolabeled ATP, separated by SDS-PAGE, and visualized by autoradiography as described 
previously (73).  Briefly, skinned cardiac myocytes (10 µg) were incubated with the catalytic 
subunit of PKA (3 to 5 µg/mL) and 50 µCi [γ-32P]ATP for 30 minutes.  The reaction was 
stopped by the addition of electrophoresis sample buffer and heating at 95°C for 3 minutes.  
The samples were then separated by SDS-PAGE, silver stained, dried, and subsequently 
exposed to x-ray film for visualization.  Individual radiolabeled protein bands were then 
excised from the gel and quantified using a scintillation counter (Packard 1900 TR).  
Stoichiometric cTnI phosphate incorporation was calculated using the following equation: 
cpm cTnI/[cTnI] · [Pi]/cpm total = [Pi]/[cTnI], where all concentrations are in moles and cpm 
is counts per minute.  MyBP-C phosphate incorporation was assessed in the same manner. 
 
Statistics 
 Comparisons between sedentary and exercised samples for force, normalized and 
absolute power outputs, ktr, and all biochemical analysis were made using a Student t-test.  p 
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< 0.05 was chosen as indicating significance.  All values are expressed as means ± SD unless 
otherwise noted. 
 
RESULTS 
Animal Model 
 
Exercise trained miniature Yucatan swine had lower body weight (BW) than 
sedentary counterparts (~20%; p = 0.003) with no difference in heart weight (HW) (Table 
4.1).  However, because of the reduction in body weight there was a ~25% increase in HW to 
BW ratio (HW:BW) (p = 0.005).  In addition to increased HW:BW the efficacy of the 
training protocol was characterized by an increase in exercise tolerance, as indexed by an 
increase in time to exhaustion during treadmill performance tests, and increased deltoid 
muscle citrate synthase activity (Table 4.1).  Taken together these central and peripheral 
markers of training provide confirmation that the treadmill training protocol was effective in 
producing a trained state. 
 
Myocyte Studies 
 
 Ventricular hypertrophy often occurs in animals undergoing stringent training 
paradigms and is commonly due to the enlargement and elongation of individual myocytes 
(for review see (96)).  Our myocyte preparations were not different in length, width or 
overall volume (Table 4.1).  However, the possibility of enlargement or elongation is 
possible as a quantitative assessment of a large number of enzymatically isolated single 
myocytes was not performed in our study.  Nevertheless, mechanical measurements are 
expressed relative to myocyte size when applicable to correct for any size-induced  
variability.  Myocyte preparation mechanical measurements are summarized in table 4.2.  
Previous studies in cardiac myocytes have reported either no change (25) or increased  
 
Table 4.1.  Animal morphologies with indices of training and myocyte measurements. 
 
 Sedentary Exercise Trained 
Body Wt (kg) 48.0 ± 5.8 38.5 ± 2.5* 
Heart Wt (g) 213.0 ± 24 214.0 ± 34 
Heart Wt / Body Wt 4.44 ± 0.25 5.53 ± 0.62* 
Duration of performance test, 
initial (min) 25.2 ± 3.9 23.7 ± 2.8 
Duration of performance test, 
final (min) 23.1 ± 3.3 37.3 ± 6.1* 
Citrate synthase activity 
(µmol·min-1·mg protein-1) 15.4 ± 3.8 23.0 ± 2.6* 
Myocyte length (µm) 142.1 ± 36.7 158.1 ± 25.8 
Myocyte width (µm) 20.8 ± 5.7 24.6 ± 6.3 
Myocyte volume (µg) 0.077 ± 0.03 0.073 ± 0.03 
Myocyte SL, pCa 9.0 (µm) 2.46 ± 0.05 2.39 ± 0.08 
Myocyte SL, pCa 4.5 (µm) 2.41 ± 0.08 2.33 ± 0.02 
  
 
 
Values are means ± SD.  * indicates p < 0.05 vs. Sedentary.  SL, sarcomere length. 
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maximal force (163) following exercise training.  In this study, we found no difference in 
absolute force production between myocytes from SED (28.6 ± 10 kN·m2) and EX (28.4 ± 13 
kN·m2) animals at pCa 4.5.   
 
The primary aim of the study was to assess differences in power output between 
myocytes from sedentary and exercise trained Yucatan miniature swine.  We found peak 
absolute power output in myocytes from exercise trained animals to be ~57% higher than 
myocytes from sedentary animals (SED = 0.42 ± 0.2 µW/mg vs. EX = 0.66 ± 0.2 µW/mg, p 
= 0.02).  Figure 4.1 shows a representative force-velocity and power-load relationship of 
skinned cardiac myocytes taken from both exercise trained and sedentary myocardium.  The 
force-velocity relationship (shown in the top panel) displays similar maximal force 
production between myocytes, but the myocyte from exercise trained myocardium has less 
curvature of the force-velocity relationship resulting in faster rates of shortening at 
intermediate loads.  The bottom panel shows the power-load relationship for these two 
preparations.  The EX myocyte had higher power output at most loads with the greatest 
difference occurring at peak power output.  The inset graph shows peak power output points 
from each SED and EX myocyte, with EX preparations exhibiting enhanced power 
generating capacity.   
 
Another way to observe changes in velocity of shortening and power output is to 
normalize the data to the maximal isometric force of each preparation; this allows assessment 
of shortening velocity at a given load.  Interestingly, the force-velocity relationship has  
 
  79
Ta
bl
e 
4.
2.
  M
yo
cy
te
 m
ec
ha
ni
ca
l p
ro
pe
rti
es
 fr
om
 se
de
nt
ar
y 
an
d 
ex
er
ci
se
 tr
ai
ne
d 
m
in
ia
tu
re
 Y
uc
at
an
 sw
in
e.
V
al
ue
s a
re
 m
ea
n 
± 
SD
.  
D
iff
er
en
ce
s w
er
e 
co
ns
id
er
ed
 si
gn
ifi
ca
nt
 a
t p
 <
 0
.0
5.
  P
o, 
is
om
et
ric
 fo
rc
e.
  F
op
t, 
fo
rc
e 
at
 w
hi
ch
 p
ea
k 
po
w
er
 
oc
cu
rs
.  
V
op
t, 
ve
lo
ci
ty
 a
t p
ea
k 
po
w
er
. M
L,
 m
us
cl
e 
le
ng
th
.  
* 
in
di
ca
te
s p
 <
 0
.0
5 
vs
. s
ed
en
ta
ry
 v
al
ue
.
1.
3 
±
0.
5
0.
02
2 
±
0.
00
4*
0.
67
 ±
0.
20
*
43
.9
 ±
17
.1
*
0.
04
1 
±
0.
02
*
0.
15
 ±
0.
04
0.
16
 ±
0.
03
28
.4
 ±
13
Ex
er
ci
se
 
Tr
ai
ne
d
1.
6 
±
0.
3
0.
01
6 
±
0.
00
4
0.
42
 ±
0.
18
 
25
.3
 ±
16
.0
0.
02
2 
±
0.
01
0.
12
 ±
0.
04
0.
14
 ±
0.
04
28
.6
 ±
10
Se
de
nt
ar
y
k t
r
(s
-1
)
Pe
ak
 n
or
m
al
iz
ed
 
po
w
er
 o
ut
pu
t 
(P
/P
o·M
L·
s-
1 )
Pe
ak
 a
bs
ol
ut
e 
po
w
er
 o
ut
pu
t  
   
 
(m
W
·m
g-
1 )
Pe
ak
 a
bs
ol
ut
e 
po
w
er
 o
ut
pu
t  
   
 
(p
W
)
a/
P o
V
op
t
(M
L·
s-
1 )
F o
pt
(P
/P
o)
M
ax
im
um
 
Fo
rc
e 
(k
N
·m
-2
)
Ta
bl
e 
4.
2.
  M
yo
cy
te
 m
ec
ha
ni
ca
l p
ro
pe
rti
es
 fr
om
 se
de
nt
ar
y 
an
d 
ex
er
ci
se
 tr
ai
ne
d 
m
in
ia
tu
re
 Y
uc
at
an
 sw
in
e.
V
al
ue
s a
re
 m
ea
n 
± 
SD
.  
D
iff
er
en
ce
s w
er
e 
co
ns
id
er
ed
 si
gn
ifi
ca
nt
 a
t p
 <
 0
.0
5.
  P
o, 
is
om
et
ric
 fo
rc
e.
  F
op
t, 
fo
rc
e 
at
 w
hi
ch
 p
ea
k 
po
w
er
 
oc
cu
rs
.  
V
op
t, 
ve
lo
ci
ty
 a
t p
ea
k 
po
w
er
. M
L,
 m
us
cl
e 
le
ng
th
.  
* 
in
di
ca
te
s p
 <
 0
.0
5 
vs
. s
ed
en
ta
ry
 v
al
ue
.
1.
3 
±
0.
5
0.
02
2 
±
0.
00
4*
0.
67
 ±
0.
20
*
43
.9
 ±
17
.1
*
0.
04
1 
±
0.
02
*
0.
15
 ±
0.
04
0.
16
 ±
0.
03
28
.4
 ±
13
Ex
er
ci
se
 
Tr
ai
ne
d
1.
6 
±
0.
3
0.
01
6 
±
0.
00
4
0.
42
 ±
0.
18
 
25
.3
 ±
16
.0
0.
02
2 
±
0.
01
0.
12
 ±
0.
04
0.
14
 ±
0.
04
28
.6
 ±
10
Se
de
nt
ar
y
k t
r
(s
-1
)
Pe
ak
 n
or
m
al
iz
ed
 
po
w
er
 o
ut
pu
t 
(P
/P
o·M
L·
s-
1 )
Pe
ak
 a
bs
ol
ut
e 
po
w
er
 o
ut
pu
t  
   
 
(m
W
·m
g-
1 )
Pe
ak
 a
bs
ol
ut
e 
po
w
er
 o
ut
pu
t  
   
 
(p
W
)
a/
P o
V
op
t
(M
L·
s-
1 )
F o
pt
(P
/P
o)
M
ax
im
um
 
Fo
rc
e 
(k
N
·m
-2
)
1.
3 
±
0.
5
0.
02
2 
±
0.
00
4*
0.
67
 ±
0.
20
*
43
.9
 ±
17
.1
*
0.
04
1 
±
0.
02
*
0.
15
 ±
0.
04
0.
16
 ±
0.
03
28
.4
 ±
13
Ex
er
ci
se
 
Tr
ai
ne
d
1.
6 
±
0.
3
0.
01
6 
±
0.
00
4
0.
42
 ±
0.
18
 
25
.3
 ±
16
.0
0.
02
2 
±
0.
01
0.
12
 ±
0.
04
0.
14
 ±
0.
04
28
.6
 ±
10
Se
de
nt
ar
y
k t
r
(s
-1
)
Pe
ak
 n
or
m
al
iz
ed
 
po
w
er
 o
ut
pu
t 
(P
/P
o·M
L·
s-
1 )
Pe
ak
 a
bs
ol
ut
e 
po
w
er
 o
ut
pu
t  
   
 
(m
W
·m
g-
1 )
Pe
ak
 a
bs
ol
ut
e 
po
w
er
 o
ut
pu
t  
   
 
(p
W
)
a/
P o
V
op
t
(M
L·
s-
1 )
F o
pt
(P
/P
o)
M
ax
im
um
 
Fo
rc
e 
(k
N
·m
-2
)
Figure 4.1 
SED EX 
Pe
ak
 A
bs
ol
ut
e 
Po
w
er
 O
ut
pu
t (
m
W
 * 
m
g-
1 )
0.0
0 .2
0 .4
0 .6
0 .8
1 .0
0 1 2 3 4 5 6 7 8 9 10
V
el
oc
ity
 ( µ
m
/s
ec
)
0
10
20
30
40
50
60
70
80
90
100
Force (µN)
0 1 2 3 4 5 6 7 8 9 10
Po
w
er
 O
ut
pu
t (
pW
)
0
10
20
30
40
50
 
Figure 4.1.  Representative absolute force-velocity and power-load relationships in 
myocyte preparations from sedentary and exercise trained pigs. 
A.  Absolute force-velocity and power-load relationships of myocytes from (○) sedentary and 
(●) exercise trained pigs.  Isometric force was similar between preparations but loaded 
shortening velocity was faster in the EX myocyte, resulting in greater peak power output.  B.  
Plot of peak power data points for individual cells from each pig.  SED myocytes displayed 
lower power values than EX myocytes.  Bar indicates the mean ± S.D. for data points. 
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similar loaded shortening velocities at most high and low loads.  However, shortening 
velocity between 10% and 25% relative force was significantly higher in myocytes from 
exercise trained pigs.  These loads correspond to peak power output and are most 
physiologically relevant as they are thought to be the loads encountered by the heart in vivo.  
Normalized peak power output also was significantly higher in myocytes from EX pigs (SED 
0.016 ± 0.003 P/Po ML· s-1, EX 0.022 ± 0.005 P/Po ML· s-1).  A similar increase in 
normalized peak power output, as well as a similar decrease in curvature (a/Po) of the force-
velocity relationship, has been reported in rat cardiac myocytes following exercise training 
(25).
 
We also addressed the effects of exercise training on the rate of myocyte force 
development following a mechanical perturbation.  The rate of force redevelopment was 
determined in the presence of maximal Ca2+ and is thought to be limited by the rate that 
cross-bridges activate the thin filament (141).  An increase in the rate of force redevelopment 
would allow more rapid ventricular pressure development and thus more time to be spent in 
the ejection phase of the cardiac cycle.  We found no difference in the rate constant of force 
redevelopment (ktr) between myocytes from sedentary and exercise trained animals (SED 1.6 
± 0.3 ML· s-1; EX 1.3 ± 0.5 ML· s-1), suggesting that the rate of force development 
independent of Ca2+ handling plays a minimal role in augmenting ventricular performance 
following exercise training. 
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Biochemical Analysis 
MyHC expression was similar between SED and EX left ventricle homogenate 
samples with the β-MyHC isoform accounting for all MyHC content.  However, some 
individual myocytes did contain detectable amounts of α-MyHC protein indicating that a 
fraction of cells from the left ventricle expressed α-MyHC.  All myocytes used in mechanical 
measurements appeared to contain only β-MyHC based on SDS-PAGE analysis.  In addition, 
because changes in cTnT isoform content have been implicated in functional changes that 
occur in a diabetic/dyslipidemic exercise pig model (74), we examined whether relative cTnT 
isoform contents were different between pig populations. Three distinct isoforms of cTnT 
were expressed (so named cTnT1, cTnT2, and cTnT3 in accordance with each isoform's SDS-
PAGE migration pattern).  Relative cTnT isoform content was similar between SED (58 ± 
7% cTnT1, 29 ± 5% cTnT2, and 13 ± 4% cTnT3) and EX myocardium (57 ± 7% cTnT1, 30 ± 
5% cTnT2, and 13 ± 5% cTnT3).   
 
 Basal PKA-induced phosphorylation of myofibrillar proteins was assessed using a 
back-phosphorylation assay (73).  Autoradiograms following SDS-PAGE separation 
displayed phosphorylation of MyBP-C and cTnI.  Stoichiometric analysis of phosphate 
incorporation in cTnI yielded measurements of 1.2 ± 0.2 and 0.7 ± 0.2 µmol of Pi / µmol 
protein (p < 0.05) in SED and EX samples, respectively.  Decreased Pi incorporation 
indicates a higher baseline phosphorylation of this protein.  Pi incorporation into MyBP-C 
followed the same trend as cTnI with EX animals having less incorporation than the SED 
control (SED 2.2 ± 0.8 µmol of Pi / µmol protein, EX 1.5 ± 0.5 µmol of Pi / µmol protein),  
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however this difference in phosphorylation was not statistically significant (p = 0.10).  The 
disparity between cTnI and MyBP-C may be that PKC is also known to phosphorylate 
MyBP-C at the same residues as PKA, but at different residues on cTnI.  Analysis of PKC-
induced phosphorylation could not be performed because of inadequate myocardial sample.  
The finding of higher baseline cTnI phosphorylation may contribute to increased loaded 
shortening and power output in EX myocytes since PKA phosphorylation has previously 
been shown to increase power output in rat myocytes (52). 
 
DISCUSSION 
Effects of exercise on force-velocity properties and power output. 
The purpose of this study was to evaluate myocytes from a pig model of exercise 
training for mechanical changes intrinsic to the myofilaments.  We found that myocytes 
obtained from exercise trained myocardium generated greater peak power output than 
sedentary counterparts despite producing similar isometric force when normalized to 
preparation size.  This is important as it defines the difference in power output was a 
consequence of altered cross-bridge interaction kinetics of the myofilaments as opposed to 
hypertrophy of the cell to increase the quantity of myofilaments.   
  
Absolute power generating capacity of a cardiac myocyte is determined by the 
number and rate of cycling cross-bridges.  The number of cross-bridges strongly bound and 
in the force-generating state determines maximum force development.  Conversely, at very 
low forces the muscle shortens at very high speeds, with the maximal velocity thought to be 
limited bythe rate of detachment of cycling cross-bridges.  It is this relationship between 
                                   Figure 4.2 
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.2.  Effect of PKA-induced phosphorylation on SED and EX myocytes.   
 for an autoradiogram showing representative phosphate incorporation into MyBP-
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force and velocity that determine power output.  In this study, force was unchanged yet 
velocity at intermediate loads (10 and 25% isometric) increased in cardiac myocytes from 
EX pigs, as compared to SED controls.  This increase in loaded shortening velocity 
corresponded to an increase in peak power output.  The increase in loaded shortening and 
power output can be the result of, as stated above, either an increase in the number of force-
generating cross-bridges bound at loads around Fopt or an increase in the rate of cycling 
cross-bridges.  As there was no observed change in isometric tension between SED and EX 
myocytes, then it becomes likely that exercise training induced an increase in the rate of 
cycling of the cross-bridges at intermediate loads.   
 
Previously it has been shown that phosphorylation of the myofibrillar proteins cTnI 
and MyBP-C by PKA produced a similar increase in absolute power in rat skinned cardiac 
myocytes (52).  However, in that study there were increases in isometric tension and loaded 
shortening velocities over a greater range of loads following PKA-induced phosphorylation.  
Although the exact reasons for these differences are not known, they certainly may arise 
from differences in types of animals, phosphorylation by other kinases or variations in 
contractile protein isoform expression.  Regarding the latter possibility, it may be that MyHC 
composition imparts dissimilar regulation of cross-bridge kinetics following PKA-induced 
phosphorylation, resulting in a reduction of loads where cross-bridge cycling is increased.  In 
agreement with this, α-MyHC ATPase activity and the rate cycling cross-bridges have been 
reported to be more responsive to β-adrenergic stimulation than preparations containing β-
MyHC (60, 161).  Regarding possible changes in contractile protein isoforms, it has been 
shown previously that a small increase in α-MyHC protein expression in rat skinned cardiac 
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myocytes produced a significant increase in power output capacity (51).  Additionally, some 
studies have reported increased α-MyHC content in rat cardiac myocytes following various 
exercise regimes such as progressive treadmill training (66), sprint training (171) and 
swimming (64, 106).  While others have reported no change in MyHC isoform content after 
training (25, 96) including previous work on Yucatan miniature swine following the same 
training protocol (77).  Our work is in agreement with the previous work in pigs in that we 
did not observe any change in MyHC expression in samples from ventricular homogenates.  
We did however detect α-MyHC in a small proportion of myocyte preparations but it was not 
detected in any myocyte preparations from which mechanical measurements were made.  
The fact that power output was greater in myocytes from exercise trained pigs with no 
change in MyHC content is in agreement with a recent study finding an increase in rat 
myocyte power output following treadmill training with no change in MyHC expression (25).   
 
Recently, a correlation between myocardial cTnT isoform expression and ventricular 
fractional shortening was reported in a pig model of exercise in combination with 
diabetes/dyslipidemia (74).  With diabetes cTnT content shifted toward greater expression of 
lower molecular weight cTnT isoforms (cTnT2 and cTnT3) when compared to control pigs, 
and moderate endurance exercise prevented the cTnT isoform shift and improved fractional 
shortening of the ventricle.  In the present study, however, SED and EX myocardium had 
similar cTnT isoform contents, indicating cTnT isofrom expression was not a contributor to 
the greater power output reported in EX myocytes. 
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β-adrenergic signaling pathway following exercise training. 
Multiple studies have found increased left ventricular responsiveness to β-adrenergic 
stimulation following exercise training (48, 136).  The means of increased responsiveness 
could be an increase in any part of the signaling pathway: catecholamines, β-adrenergic 
receptors, receptor G-proteins, or adenylate kinase expression/activity.  Some of these have 
been reported not to be increased following exercise training (circulating catecholamines 
(111) and β-adrenergic receptor density(48)), while others do increase (β-adrenergic receptor 
Gs subunits or ratio to Gi (11, 48, 122) and basal and peak adenylate cyclase activities (11, 
126)).  Ultimately the end result of enhanced β-adrenergic stimulation is increased 
phosphorylation of intracellular target proteins at the plasma membrane (L-type Ca2+ 
channel) and myofibrillar apparatus (cTnI and MyBP-C).  Phosphorylation of L-type Ca2+ 
channels leads to a greater magnitude of Ca2+ in the cell, however no increase in intracellular 
Ca2+ transients following exercise training has been observed in myocytes (79, 107, 163).  
Here we do report an increase in phosphorylation of the myofibrillar apparatus at cTnI with a 
trend for higher phosphorylation in MyBP-C as well.  A difference in phosphorylation of the 
two proteins may signify PKC involvement as cTnI is phosphorylated by PKC, on a different 
site than PKA, while MyBP-C phosphorylation by PKC occurs on the same sites as those 
phosphorylated by PKA.  This could not be distinguished experimentally. 
 In conclusion, we found peak power generating capacity to be greater in myocytes 
from chronically exercise trained pigs as compared to sedentary counterparts.  The 
mechanisms creating this difference is not known, but a potential contributor may be greater 
PKA-induced phosphorylation of myofilament proteins cTnI and MyBP-C in EX myocytes.  
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Overall, the results suggest that changes in contractile properties intrinsic to individual 
myocytes may contribute, at least in part, to the enhanced ventricular function associated with 
exercise training. 
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Chapter 5.      DISCUSSION 
 
 
5.1 Summary of Results 
 
Myocardial performance depends on many factors including the architecture of the 
ventricles, aortic pressure, and the contractile state of the myocardium.  Myocardial 
performance can be altered in times of stress whether it be acute stress such as ischemia or 
chronic stress such as endurance exercise training.  My work has focused on the effects that 
ischemia and endurance training have on altering the contractile state of myofibrils, which is 
a key determinant of overall myocardial performance.  I have determined the effects of 
metabolites that rise during ischemia (Pi and H+) on the functional capacity of permeabilized 
myocyte preparations.  Moreover, alterations in function were measured in myocytes 
expressing either α- or β-MyHC to ascertain differences in ischemic tolerance, as isoform 
content is known to be altered in pathological states.  It was found that Pi and H+ alone and 
together decreased power generating capacity of α-MyHC while only in combination did 
they diminish β-MyHC myocyte power.  The greater tolerance toward ischemic conditions 
was attributed to a Pi and H+ induced increase in the velocity of loaded shortening.  In 
addition, Pi-induced changes in contractile properties of α-MyHC myocytes were more 
thoroughly assessed to probe the states of the cross-bridge cycle states that are most 
important in determining power output.  Power near isometric loads is most likely limited by 
force-generating transitions that limit isometric force (i.e., the balance between attachment 
and detachment of positively strained cross-bridges), while power at very low loads is most 
likely limited by the cross-bridge transitions that limit maximal shortening velocity (Vmax) 
(i.e., detachment of compressively strained cross-bridges).  Experiments here utilized Pi to 
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increase one of these processes (i.e., force-generating transition rates) without affecting the 
other process (i.e., detachment of compressively strained cross-bridges) in order to determine 
which is most important in determining power output at intermediate loads where muscles 
tend to operate in vivo.  Pi increased loaded shortening velocity over most of the load range 
without any effect on Vmax, implying that cross-bridge steps associated with Pi release (i.e., 
force-generating transitions) are the most important in determining power output over 
physiological relevant loads.  Finally, a pig model of endurance exercise training was used to 
determine if changes intrinsic to the myocardial myofilaments were, in part, responsible for 
greater SV that occurs with exercise training.  Increased peak power generating capacity was 
observed in myocytes from exercise trained animals as compared to sedentary controls.  One 
potential mechanism for this change in contractile function was found to be an increase in 
PKA-induced phosphorylation of myofibrillar proteins.  These results provide a molecular 
and cellular basis for functional changes observed acutely and chronically with stress.  In 
addition, they provide insight into chemomechanical steps of the cross-bridge cycle that 
determine loaded shortening and power output of cardiac myocytes.         
 
5.2 Determinants of myocyte power output 
 Muscle power is the product of force and velocity and it known to reach an optimum 
at intermediate forces or loads that the muscle is working against.  One aspect of my work 
focused on defining the chemomechanical cross-bridge states that are most important in 
determining maximal power output (i.e., at intermediate load ranges).  To begin this 
discussion, I will first discuss the force-velocity relationship and the factors thought to 
determine the slopes of curvature of the relationship.  Next I will incorporate the 1957 
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Huxley model of muscle contraction (63) in an attempt to quantify how factors such as Pi, 
H+, and phosphorylation of myofibrillar proteins alter force-velocity curvature and overall 
power by affecting rate constants of cross-bridge transitions.  Then, I will provide discussion 
of specific chemomechanical cross-bridge states likely corresponding to the transitions that 
regulate power output over most loads. 
 
The force-velocity relationship is well defined by a rectangular hyperbole with force 
decreasing with increased velocity.  The fall in force with increased velocity is hypothesized 
to arise from two factors, one is decreased number of cross-bridges exerting positive force 
and the other is increased number of compressively strained cross-bridges that form as the 
muscle shortens and oppose normal force production.  At high force the first of these 
processes (i.e., decreased number of cross-bridges exerting positive force) is thought to be 
most important and determines the slope of the force velocity curve near isometric force.  At 
high velocities (low loads) the second process (i.e., increased number of cross-bridges 
exerting compressive force) is thought to be most important and determines the slope near 
Vmax.  The curvature of the force-velocity relationship (i.e., a/Po) is determined by the ratio of 
these two slopes and, thus, its value indicates the relative contribution of these two processes.   
 
A shift in force velocity curvature with Pi addition, lowered pH, and myofibrillar 
phosphorylation may indicate which process, either number of force generating cross-bridges 
or detachment of compressed cross-bridges, are limiting power output over a wide range of 
relative loads.  First, a reasonable assumption is that power output at very low loads is 
limited, like Vmax, by the detachment rate of cross-bridges.  On the other hand, at high loads 
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(i.e., near isometric force) where filament sliding is minimal, power output is most likely 
limited by cross-bridge attachment rates or transition rates from weakly-bound to strongly-
bound force-generating cross-bridges.  Conceptually, at these high loads, rates of cross-
bridge attachment are predicted to limit power output by dictating how many force-
generating cross-bridges interact with thin filaments that slide past cross-bridges at a constant 
velocity.  For example, if force-generating transitions are relatively slow, then slow 
shortening rates are needed to accumulate enough force-generating cross-bridges to support a 
high load.  Slower shortening rates would yield relatively low power output compared to a 
situation where faster attachment rates could accommodate higher shortening velocities.  If 
indeed, power output at low loads is determined by cross-bridge detachment whereas power 
output at high loads is determined by cross-bridge attachment and force generation, the 
question arises as to where in the power-load curve does the limiting step shift from cross-
bridge detachment to force-generating transitions.  Determining this transition point would 
provide evidence regarding the chemomechanical steps that are most important in 
determining power output at intermediate loads where muscles operate in vivo.  If for 
instance, power output is determined by force- generating transitions only at relatively high 
loads, then maximum power output is most likely regulated by cross-bridge detachment rates.  
If, on the other hand, the shift between force generating transitions and cross-bridge 
detachment rates occurs at very low loads (eg., less than 20% isometric force), then kinetics 
of cross-bridge attachment and force generating transitions probably determine maximum 
power output.  Addition of Pi increased the velocity of loaded shortening over most loads 
(15-100% isometric) making the relationship less curved and more shallow (i.e. a greater 
a/Po) (Tables 2.2, 3.1, and 3.2).  Since Pi release is intimately linked to force generation (53) 
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this indicates force-generating transitions are involved.  These observations of changes in 
curvature at moderate to high loads appears to indicate force-generating transitions as the 
primary process determining optimum power.   
 
An alternative, more quantitative method of determining the impact of Pi, H+, and 
myofibrillar phosphorylation on force-velocity relationships is to fit my data to the Huxley 
model (63) of muscle contraction (equation 5.1).  The model discusses cross-bridges in terms 
of force-generating and non-force generating populations.  Furthermore, force-generating 
cross-bridges can be either positively strained, contributing to force production and muscle 
shortening, or negatively strained, opposing force production and shortening.  Application of 
these terms to describe muscle contraction and the relationship between force (P) and 
velocity (V) is shown by the equation (63):  
(5.1)  P = kf1/( f1 + g1) {(1 – exp [-(f1 + g1) h/ V]} {1 + (1/2)[( f1 + g1)/g2]2 [V/( f1 + g1)h]} 
In this equation f1 is the rate constant of positively strained cross-bridge attachment, g1 is the 
rate constant of positively strained cross-bridge detachment, g2 is the rate constant of 
detachment of negatively strained cross-bridges, and h is a constant related to the distance 
over which a cross bridge may attach.  The interaction of these constants define the 
characteristics of the force-velocity relationship with the shape of curve between the two 
extreme points (isometric force and Vmax) determined by the factors that regulate each of the 
extremes.  In this model, isometric force is limited by the number of positively strained 
cross-bridges (i.e., force-generating) which can be increased or decreased by changing the 
rates of attachment (f1) or detachment (g1) in the following relationship: 
(5.2)       f1/(f1 + g1)
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The other end of the force-velocity relationship is Vmax which is proposed to be 
limited by the amount of negatively strained cross-bridges and is defined by g2.  Negatively 
strained cross-bridges build up as the muscle moves at higher velocities and the filament 
sliding speed at which force of positively strained cross-bridges equals force of negatively 
strained cross-bridges is Vmax.  Thus, curvature of the force-velocity relationship is 
determined by the interaction of force-generating transitions and detachment processes.  The 
Huxley model defines curvature as: 
(5.3)     (f1 + g1)/g2
Here, high values of (f1 + g1) relative to g2 decreases curvature.  Conversely, increased g2 
relative (f1 + g1) increases curvature.  The inverse nature of the constants ((f1 + g1) and g2) 
and how they alter force-velocity and power-load relationships is shown in Figure 5.1.  
Relative to a given relationship (middle force-velocity curve) changes in force-velocity 
curvature toward a more shallow curve are completed by either increasing f1 and g1 (2(f1 + 
g1)) or decreasing g2 (0.5 g2).  A shallower force-velocity relationship results in greater 
relative peak power.  Alternatively, a more curved relationship is formed when f1 and g1 are 
decreased (0.5 (f1 + g1)) or g2 is increased (2 g2), resulting in less relative power. 
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        Absolute force (P) and velocity (V) data from each experiment with Pi addition were 
modeled using Sigmaplot software to quantify rate constants to explain changes in curvature.  
The Huxley equation (Equation 5.1) was solved for the variables (f1 + g1) and g2.  The data 
yielded the following results (in s-1): 
Table 5.1. 
 0 mM 2.5 mM 5 mM 10 mM 
(f1 + g1) 8.1 ± 1.1 9.6 ± 0.8* 10.1 ± 0.7* 10.9 ± 1.9* 
g2 147.8 ± 1.6 148.8 ± 0.7 148.7 ± 0.9 150.0 ± 1.3* 
 
Increasing [Pi] progressively increased the sum of the rate constants of attachment and 
detachment of positively strained cross-bridges (i.e., f1 + g1) without altering g2 (except with 
10mM compared to 0mM).  A larger (f1 + g1) relative to g2 increases the rate of force-
generating cross-bridge interaction according to this model, implying faster cycling of 
positively strained cross-bridges.  This is consistent with a shallower slope as, there would be 
a greater probability of cross-bridge attachment and transition to force-generating states at a 
given speed of thin filament sliding.  In addition, g2 was not changed or was slightly larger 
with increasing [Pi], so it would have negligible effects on curvature.  Importantly the effect 
of Pi on g2 was also assessed mechanically to provide an estimate of g2 for the model and 
provide further evidence of lack of a Pi effect.  Vmax was not altered by increasing Pi 
concentrations according to force-velocity relationships, however attaining Vmax in this 
manner requires an extrapolation in a range of data that can have high variability.  An 
alternative method is to measure the unloaded shortening velocity (Vo) of muscle using a 
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series of slack steps.  Vo measurements are in agreement with Vmax from force-velocity 
curves and g2 calculations from the Huxley model showing no effect of Pi addition on Vmax, 
which is thought to be limited by the rate of detachment of negatively strained cross-bridges.   
 
Comparison of α-MyHC and β-MyHC myocyte data with additional Pi and H+ alone 
and in combination using the Huxley model provided the following values: 
Table 5.2. 
 pH 7.0, 0 mM pH 7.0, 5 mM pH 6.6, 0 mM pH 6.6, 5 mM 
α-MyHC 
(f1 + g1) 
 
7.8 ± 0.8 
 
9.1 ± 1.0* 
 
8.4 ± 1.2 
 
8.8 ± 0.8* 
g2 147 ± 4 148 ± 2 147 ± 5 148 ± 3 
Β-MyHC     
(f1 + g1) 2.7 ± 0.2 3.4 ± 0.3* 3.3 ± 0.5* 3.5 ± 0.5* 
g2 73 ± 2 75 ± 2 75 ± 1 74 ± 1 
 
The values for α-MyHC myocytes show an increase in the sum of the rate constants of 
positively strained cross-bridges with Pi addition at either pH, but not with increased [H+] by 
itself.  The values from the Huxley model are qualitatively similar to those reported in Table 
2.1 for the effects of these conditions on absolute power.  However, with this model there is 
not discrimination between the effect of 5 mM Pi at pH 7.0 and pH 6.6.  An explanation for 
this discrepancy may be that unlike with Pi at pH 7.0 where an estimation of g2 was made 
(Vo), the effect of a lower pH on g2 was assumed to have no effect (from Vmax data 
extrapolated from force-velocity relationships).  This assumption may be incorrect though as 
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Vo has been reported to be decreased at lower pH values (120).  A smaller g2, as predicted 
from previous work (120), would contribute to a shallower force-velocity relationship 
because according to the model the ratio of (f1 + g1) to g2 would be increased. 
 
For the β-MyHC myocyte calculations g2 was assumed to be half of the value for α-
MyHC myocytes.   Since isometric force is similar between myocytes expressing α-and β-
MyHC, then f1 and g1 must change proportionately with a shift from α-MyHC to β-MyHC.  
A nearly two-fold difference in (f1 + g1) between α-MyHC and β-MyHC myocytes is within 
the range of changes reported in mechanical perturbations associated with the constants (i.e., 
ktr) (40).  Changes in (f1 + g1) were qualitatively similar to changes in peak normalized power 
in β-MyHC myocytes, with experimental conditions having a greater positive effect on (f1 + 
g1) than in α-MyHC myocytes (~17% increase in α-MyHC, ~25% increase in β-MyHC with 
5mM Pi at pH 7.0).  In addition, an underestimation of the effect of lower pH alone and in 
combination with Pi on (f1 + g1) may have occurred because of the assumption of no change 
in g2 at lower pH. 
 
Finally, myocyte force and velocity data from exercise trained and sedentary pigs 
yielded the following results:  
 
 
 
 
Table 5.3. 
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 SED EX 
(f1 + g1) 2.02 ± 0.1 2.46 ± 0.2* 
g2 50.1 ± 0.4 50.2 ± 0.5 
 
In agreement with the previous models, an increase in the sum of the rate constants 
governing force-generating cross-bridges occurred with exercise training; this yielded a 
decrease in the curvature of the force-velocity relationship.  Interestingly, (f1 + g1) were 
smaller than reported for rat β-MyHC myocytes even though both are composed of β-MyHC.  
This is in agreement with ktr and power measurements between the two species, with pig 
myocytes having ~2-fold lower ktr and peak power output values.  This modeling data 
implies an apparent increase in the rate of force-generating transitions associated with 
myofibrillar phosphorylation, consistent with previous reports (52, 60). 
 
The model implies that processes associated with force generating transitions (i.e., 
rates of positively strained cross-bridges) are the most important in determining loaded 
shortening and power output at intermediate loads where muscles perform work.  Assuming 
force-generating steps limit power at intermediate loads it becomes of interest which steps in 
the cross-bridge cycle are coupled to the changes in contractile properties.  A major 
challenge of muscle physiology lies in defining chemomechanical states during contraction.  
The two state model provides a framework to base discussion for a more complex, multi-
variant model (such as provided in the cross-bridge scheme (Figure 1.4)), which has been 
proposed to explain a multitude of muscle biochemical and mechanical data.  Increases in 
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force-generating transitions (increased f1 + g1) qualitatively describe the mechanical changes 
(e.g., changes in ktr, power and force-velocity curvature) with Pi, H+, and myofibrillar 
phosphorylation but it cannot describe the quantitative differences between these changes.  
For example, ktr and power both increased with progressive addition of Pi, but ktr increased to 
a much greater extent (~300% versus 30% at 10mM Pi, respectively).  This discrepancy can 
be rectified by a multi-state model with additional steps regulating each of the processes 
separately.   
 
The Huxley model predicts loaded shortening velocity and power output are 
determined by force-generating transitions.  Steps corresponding to force-generating 
transitions include steps 4-6 of the cross-bridge cycle model.  I propose the steps limiting 
loaded shortening to be the primary force-generating isomerization and Pi release (steps 4 
and 5).  Changing the rates of these steps (i.e., 4 and 5) during shortening may greatly impact 
mechanics by allowing cross-bridges to cycle to force-generating states faster thus 
maintaining attached force-bearing cross-bridges at higher velocities (i.e., decreased 
curvature of the force-velocity relationship).  Additionally, these steps have been reported to 
be sensitive to Pi (17, 19, 20, 39, 53, 141, 147, 156) unlike the other force-generating step 
(step 6) which is insensitive to increased concentrations of Pi because of an irreversible 
isomerization after Pi release.  Additional experiments have demonstrated the primary 
isomerization (step 4) and Pi release (step 5) to be sensitive to changes in temperature (115, 
155, 172) and length perturbations (i.e., strain) (62, 112, 116, 172).  Steps limiting power are 
thought to be sensitive to temperature as an increase in temperature increases power to a 
much greater extent than force (~20 fold compared to ~3 fold, respectively) in skeletal 
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muscle fibers (23).  Additionally, there is an inherent strain dependence of power as observed 
in the force-velocity relationship.  Sensitivities to Pi, temperature and strain all provide 
evidence for the possibility that it is the primary isomerization coupled to Pi release that 
determines loaded shortening and power output in muscle and perturbations of these steps 
will affect velocity of loaded contractions. 
ktr
As mentioned above, ktr was increased to a much greater extent than loaded 
shortening velocity by Pi addition, implying regulation by difference processes; however the 
Huxley model can not differentiate between an effect on ktr and on power.  A multi-state 
model though provides an attractive point of differentiation between the two mechanical 
processes.  One possibility is that force development is limited by the cooperative activation 
of near-neighbor regulatory units on the thin filament by strongly binding cross-bridges (37, 
39, 141) and addition of Pi increases the number of strongly binding non-force generating 
cross-bridges (A M ADP Pi), which has been reported in skeletal muscle with Pi (94, 108).  
Consistent with Pi increasing thin filament activation, like addition of strongly binding NEM 
modified cross-bridges (142), addition of Pi eliminated the slow phase of unloaded 
shortening following slack steps in skinned fast-twitch skeletal muscle fibers during 
submaximal Ca2+ activations (89).  This evidence supports the proposal that steps regulating 
activation of the thin filament and force-generating step limit ktr. 
 
 
 
Force 
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 Another way the two-state model of Huxley does not accurately describe mechanical 
findings is force declines with metabolite addition.  The model defines force as f1/(f1 + g1) 
with f1 and g1 proportional over most positive attachment distances.  Since (f1 + g1) was 
increased by metabolites (per the model), g1 would have to increase to a larger extent than f1 
otherwise force would increase or stay the same if f1 and g1 increased in proportion.  If one 
assumes isometric ATPase to estimate g1, then there appears to be little effect of Pi on g1, 
since Pi only decreases isometric ATPase to a very small degree (<5% per decade of Pi) and 
to a lesser extent than force (27).  A multi-variant model of muscle contraction provides a 
better means of describing the declines in force with Pi and H+ addition.  Pi release is coupled 
to the primary force-generating state so an increase in [Pi] can cause the reversal of the force-
generating step (20, 53), leaving fewer cross-bridges to produce force.  In addition, as Pi 
decreases ATPase rate less than force it can be surmised that force per cross-bridge may also 
be decreased.  Similar to Pi, reduction of force at lower pH may be the result of a shift in 
cross-bridge populations toward non-force generating states because a proton is thought to be 
lost during the force-generating transition (1).  Lowering the pH would then effectively shift 
cross-bridge populations back to a pre-force generating state.  However, this is not likely the 
only way in which H+ decreases myofibrillar force because a reduction in force of rigor 
cross-bridges (32) and stiffness per cross-bridge (91) occur with decreased pH indicating 
force per cross-bridge is also declined.  Therefore, the effect of pH on isometric force is most 
likely a combination of a decrease in the number cross-bridges and the force generated per 
cross-bridge.  From this discussion it can be seen a more complex model of muscle 
contraction is needed to accurately describe mechanical changes with Pi and H+. 
5.3 MyHC dependent sensitivity to metabolites 
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Another interesting and novel finding presented here is a description of MyHC 
dependence of  mechanics in response to ischemic metabolites (Figure 3.4 and Tables 3.1 and 
3.2).  Measurements of mechanical changes with ischemic metabolites in cardiac muscle 
have primarily been limited to isometric properties (i.e., isometric force and Ca2+-senstivity 
of force).  Moreover, mechanical changes in response to ischemic metabolites have not been 
investigated with consideration to MyHC content, which is highly correlated to many 
dynamic processes (Vmax, ktr and power) (40, 72).  I found isometric force and its response to 
ischemic metabolites was not different between MyHC myocyte populations.  During 
isometric contraction, there is no shortening so cross-bridges are either detached or positively 
contribute to force generation so the cross-bridge cycle is likely limited by the attachment 
and detachment of positively strained bridges (f1 and g1, respectively; according to the two-
state model).  Because isometric force is similar between myocytes expressing α-and β-
MyHC, then f1 and g1 must change proportionately with a shift from α-MyHC to β-MyHC.  
A proportional shift in these processes is not surprising as many mechanical changes thought 
to be associated with attachment and detachment rates are altered in a linear fashion with the 
shift from α-MyHC to β-MyHC (Vmax and ktr) (40, 72).  In contrast to the lack of MyHC 
dependence of isometric forces with ischemic metabolites, there was a striking difference in 
how MyHC affected power output response to ischemia metabolites.  Absolute power output 
was more greatly reduced in α-MyHC myocytes than in β-MyHC myocytes.  This was the 
product of a greater Pi-induced increase in loaded shortening velocity and an exclusive H+-
induced increase of loaded shortening velocity in β-MyHC myocytes.  Others studies 
examining a potential MyHC dependent effect on dynamic contractile properties are limited.  
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For example, in skeletal muscle fibers no difference was observed in the Pi effect on power 
generating capacity of fast-twitch and slow-twitch muscle fibers (23).  However, in this study 
when temperature was increased toward physiological conditions (30° C), slow-twitch 
muscle fiber power generating capacity increased 20-fold, whereas fast-twitch power 
generating capacity increased ~7 fold, with no difference in force production between fiber 
types (23).  A greater effect of temperature on muscle power may indicate steps limiting 
power generation have fiber-type sensitivity to temperature.  This idea is in agreement with 
data comparing the effect of temperature on cross-bridge rate constants from fast- and slow-
twitch muscle fibers (22, 155).  Wang and Kawai measured a greater than 2 fold difference in 
temperature sensitivity of the force-generating step (step 4 here) between fast-twitch and 
slow-twitch muscle fibers (Q10 = 3.3 and 6.7, respectively) (155).  Further evidence suggests 
the force-generating step is more closely coupled to the Pi release step in slow twitch skeletal 
muscle (same MyHC as cardiac β) and intermediate skeletal muscle (i.e., type IIa MyHC 
fiber) than in fast twitch skeletal muscle, with slow being greater than intermediate (22).  
More closely coupled steps would confer greater Pi sensitivity to the primary force-
generating step as well (22).  Greater temperature dependence existing between fiber types in 
addition to changes in the coupling between the isomerization and Pi release steps that 
provide a greater Pi sensitivity for force-generating steps (22), also may provide a mechanism 
for the greater Pi-dependence of loaded shortening to ischemic metabolites observed in β-
MyHC compared to α-MyHC myocytes (Chapter 3).  
 
 
5.4 Other experimental considerations 
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 Force depression from Pi addition is concentration dependent with the relationship fit 
well by a single declining exponential (Figure 2.1).  An exponential relationship indicates 
small changes in [Pi] at low initial levels have greater impact on force inhibition than do 
changes from higher initial concentrations.  Utilization of enzyme-linked Pi “mopping” 
systems to remove Pi from solutions has shown force depression occurs with [Pi] as low as 
0.2 mM (109).  This indicates that Pi tonically inhibits force production in cardiac muscle 
even under normal conditions when [Pi] is low (1-2mM (2)).  Also, this may indicate that 
solutions used in this study may have missed this more linear region of depression as 
experimental solutions and myocyte preparations contain Pi.  To examine the relationship of 
lower concentrations of Pi it is necessary to minimize the contaminant Pi in solutions.  The 
presence of significant Pi contamination in our solutions or preparations was examined by the 
incorporation of sucrose phosphorylase (SP) and its substrates into relaxing and activating 
solutions while correcting for changes in ionic strength and balance.  This enzyme and 
protocol have been shown previously to decrease [Pi] to as low as 0.2 mM in skeletal muscle 
preparations (69, 109).  Inclusion of SP in activating solutions had no effects on myocyte 
force production, loaded shortening velocity, or power output (Figure 5.2) indicating a 
relatively low level of Pi contamination in experimental solutions, although in contrast to 
previous work in skeletal muscle preparations, this finding was not unexpected as skeletal 
preparations have upwards of 20-30 fold greater cross-sectional area and several fold greater 
length than do our myocyte preparations, meaning overall ATPase and PCr hydrolysis rates  
Figure 5.2 
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will be higher.  Thus, it is probable that contaminant [Pi] in our experiments are lower than 
those estimated in skeletal preparations (0.7 mM Pi), and possibly as low as 0-0.2mM. 
 
Differences in Pi production due to preparation size yields the possibility of 
differential response of preparations to experimental conditions because of Pi accumulation.  
In fact, some studies have demonstrated an inverse relationship between preparation diameter 
and force decline (70, 139) which is thought to exist because of lower Pi accumulation from 
myofibrillar ATPases in thinner preparations during Ca2+ activation.  Data showing force 
response to increasing [Pi] is plotted with preparation width indicated for each curve (Figure 
5.3).  Our preparations displayed limited variability in force response to Pi addition.  The 
variability that does exist is most likely the result of random selection of solution order as a 
small amount of preparation deterioration (less than 20%) is common following multiple 
force-velocity determinations.  Meaning, there may be a greater relative fall in isometric 
force with 10 mM Pi if it is the last condition examined as opposed to first.  Nevertheless, 
preparation width did not correlate with force decline to 5 mM Pi (Figure 5.3) further 
indicating preparation size did not confound the results. 
 
 Application of Pi and H+ in combination has been reported to produce a synergistic 
effect in skeletal muscle (102, 159).  The reasoning for a greater effect in combination was 
the formation of a greater amount of the diprotonated form of Pi (Pi-) at a lower pH; the Pi- 
form of Pi is exclusively responsible for force declines in skeletal muscle (102).  However, 
the results presented here and previously (69, 103) find that it is total [Pi] and not the Pi- form 
Figure 5.3 
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that is responsible for force depression in cardiac muscle.  Lack of synergy can be seen by 
examining the effects of Pi and H+ addition separately and in combination on isometric force 
production (Figure 5.4).  The top graph in Figure 5.4 has force relative to the value obtained 
at pH 7.0 with no added Pi; force depression resulted from either Pi or H+ addition, however 
the greatest effect occurred when applied in combination.  These results may suggest the Pi- 
form is responsible for the depressive effect as both increasing the [Pi] and lowering the pH 
generates a greater [Pi-], with the greatest concentration occurring when in combination.  If 
increased [Pi-] is responsible then normalizing force to the isometric value at pH 7.0 of each 
[Pi] (bottom Figure 5.4) would show disparate results at the lower pH as a greater [Pi-] would 
be present when applied in combination as opposed to just lower pH.  This however is not  
observed, indicating effects of Pi and H+ on force production are independent and additive in 
cardiac muscle, unlike skeletal.  This discrepancy has been attributed to an apparent fiber 
type difference in Pi sensitivities (103). 
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 The studies of this dissertation examined how acute changes in the ionic environment 
associated with ischemia as well as chronic stress levels induced by exercise training 
modulate myocyte function.  The results indicated that Pi decreases force production, yet 
increases loaded shortening velocity in a [Pi] dependent manner in all myocytes, attenuating 
the decline in power of α-MyHC myocytes and ablating the decline in β-MyHC myocytes.  
Since Pi release is tightly coupled to force-generating states this supports the hypothesis that 
force-generating transitions are most important in determining loaded shortening velocity and 
power output generated by cardiac myofibrils.  In addition, increased [H+] also depressed 
force in cardiac myocytes but, interestingly, increased loaded shortening exclusively in β-
MyHC myocytes.  This suggests that β-MyHC myocytes are more resistant to declines in 
power output induced by ischemic metabolites.  Finally, cardiomyocytes from exercise 
trained pig myocardium had increased power output compared to those from sedentary 
control pigs, and the increased power was associated with higher baseline PKA-induced 
phosphorylation levels of cardiac myofibrils from exercised trained pigs.  Overall, these 
alterations in ionic milieu, MyHC content, and phosphorylation status after exercise training, 
all of which increased loaded shortening velocity, are put forth as potential mechanisms to 
aid the heart’s physiological response to stress, making it more tolerant to mediators of stress 
and more capable of meeting systemic demand.  
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